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FcεRI, the high affinity receptor for immunoglobulin E (IgE), is primarily found on 
the surface of mast cells and basophils. FcεRI signaling is triggered by the crosslinking of 
receptor-bound IgE by a multivalent antigen (Ag). This initiates a series of intracellular 
signaling events that eventually lead to secretion of mediators such as histamines and 
cytokines, which are responsible for allergic reactions. In addition, Ag-crosslinked IgE-FcεRI 
complexes are internalized. Although the sequelae of signaling events leading to release of 
preformed mediators has been extensively studied, much less is known about the FcεRI 
internalization pathway.  
Recent investigations of our laboratory have focused on the roles that the plasma 
membrane and the actin cytoskeleton play in FcεRI-mediated signaling leading to secretory 
events. However, the tools available to study spatial regulation of cellular responses were 
limited. Towards overcoming this limitation, we previously developed micro/nanofabricated 
surfaces with patterned arrays of ligand to spatially control the stimuli provided to cells. This 
enabled us to visualize the formation of signaling complexes at the plasma membrane of the 
cells.  
My research has now extended the application of these micro-patterned surfaces to 
study the assembly of FcεRI endocytic machinery, in conjunction with fluorimetry, flow 
cytometry, and confocal microscopy. I found that inhibitors of F-actin cycling cause 
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crosslinked IgE-FcεRI complexes too localize in membrane invaginations that are not cleaved 
from the plasma membrane. I provided evidence that FcεRI internalization is sensitive to 
cholesterol, phosphoinositide synthesis at the plasma membrane, and the tyrosine kinase Syk. 
My experiments with micro-patterned ligand surfaces showed that recruitment of F-actin to 
the FcεRI signaling complexes is diminished in the presence of inhibitors of phosphoinositide 
synthesis. 
I have further extended the application of micro-patterned ligand surfaces to study the 
spatial regulation of epidermal growth factor (EGF) receptor (EGFR) signaling by developing 
a scheme to covalently immobilize micron-sized patches of functionally active EGF. I utilized 
NIH-3T3 cells stably over-expressing EGFR to detect the formation of EGFR signaling 
complexes via fluorescence confocal microscopy. I detected actin cytoskeleton-dependent 
recruitment of EGFR signaling partners H-Ras, MEK, and phosphorylated Erk to the EGFR 
signaling complexes on the plasma membrane of cells. In addition, I observed recruitment of 
F-actin and the adaptor protein paxillin, including phosphorylated paxillin, to regions where 
EGFR is clustered at the EGF patches. I also found that recruitment of F-actin and Erk to 
EGFR signaling complexes is diminished in the presence of inhibitors of phosphoinositide 
synthesis. Integrin α-5, the most abundant integrin in NIH-3T3 cells, is excluded from these 
EGFR signaling complexes.  These results demonstrate that micro-patterned EGF surfaces are 
valuable for investigation of spatially orchestrated interactions of signaling proteins with 
EGFR at the plasma membrane.  
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Chapter 1 
Introduction 
 
1.1 Receptor mediated signaling in cell biology: 
One of the criteria that defines life is that all living organisms are responsive to changes 
in their external environment and certain type of stimuli (1). The smallest single unit of life in 
mammals, a cell, is no exception to that rule. Over the decades, research has demonstrated that 
cells are responsive to changes in extracellular environment and to chemical or physical stimuli. 
Chemical stimuli can be caused by several kinds of molecules including proteins, peptides, 
amino acids, nucleotides, small molecules such as nitric oxide and carbon monoxide. In some 
cases, these molecules might be freely diffusing in the extracellular milieu or might be tightly 
bound to the plasma membrane of a stimulating cell. Since the inside of the cell is separated from 
the extracellular environment by plasma membrane, which is impermeable to most molecules, 
the mechanism of how changes in extracellular environment affect the cells on the inside has 
been a central topic of research. Although some molecules can easily diffuse across the plasma 
membrane of the cell, most cannot. Cells are particularly responsive to a specific class of 
molecules that act by binding to their high affinity receptors on the plasma membrane of the cell. 
Cell surface receptors are a class of transmembrane proteins that are expressed on the plasma 
membrane of the cells. They become activated upon ligand-binding and the cell initiates a 
signaling cascade eventually leading to cellular responses (5). Depending on the specific 
receptor, these may lead to a range of responses in varying cell types including migration, 
proliferation, morphological changes, gene transcription and apoptosis. A wide array of signaling 
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molecules, along with their specific, receptors on the plasma membrane of the cells, lead to 
diversity in the responses (6). 
Since receptor mediated signaling is known to regulate so many important processes in 
the cells, misregulation of these pathways has been implicated in many physiological diseases, 
including diabetes, allergic reactions to harmless substances, and cancer. Molecular 
understanding of the signaling pathway will open more avenues for exploring new drug targets in 
the effort to cure these diseases. In this dissertation, I concentrate specifically on studying two 
types of receptor mediated signaling systems: 1) FcεRI, a high affinity receptor for 
immunoglobulin E (IgE) on the surface of mast cells, which is involved in allergic responses (7), 
2) epidermal growth factor (EGF) receptor (EGFR) on the surface of fibroblasts (8), which has 
been known to be misregulated in different kinds of cancer. 
 
1.2 FcεRI receptor mediated signaling 
FcεRI, expressed on the plasma membrane of mast cells and basophils, is a high affinity 
receptor for immunoglobulin E (IgE), which binds to IgE in a 1:1 ratio. For review, see (9). 
FcεRI receptor expressed on rat basophilic leukemia (RBL) cells has proved to be a useful model 
system to study receptor mediated signaling in hematopoietic cells. Physiologically, signaling by 
IgE bound to FcεRI is initiated by an oligovalent antigen (allergen), which causes aggregation of 
IgE-FcεRI. This results in association of aggregated FcεRI receptors with ordered membrane 
domains (also referred to as ‘lipid rafts’). As depicted in Figure 1.1, crosslinking of IgE by a 
multivalent antigen leads to formation of receptor signaling complexes, which facilitates the 
recruitment of signaling partners including Src family kinase, Lyn (10), which is known to  
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Figure 1.1: Schematic demonstration of FcεRI signaling pathway: The FcεRI signaling 
pathway is initiated upon the crosslinking of IgE bound receptors on the surface of cells. 
This is followed by FcεRI receptor phosphorylation by Lyn and subsequent activation of 
Syk kinase, LAT, and PLC. PI(4,5)P2 is hydrolyzed by PLC to generate IP3 and DAG. IP3 
binds to its receptor on the ER to initiate calcium mobilization, plasma membrane bound 
DAG activates PKC. This leads to further downstream signaling events eventually resulting 
in exocytosis of secretory vesicles, in a process known as degranulation.   
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phosphorylate tyrosine residues located in the immunoreceptor tyrosine-based activation motifs 
(ITAMs) of FcεRI β and γ subunits (11). Tyrosine phosphorylation of ITAMs results in the 
recruitment and phosphorylation of Syk, a tyrosine kinase of the Syk/ZAP-70 family and Lyn 
through their Src homology-2 (SH2) domain, which in turn phosphorylates phospholipase C 
(PLC) and linker for the activation of T-cells (LAT) amongst other signaling partners. Activated 
PLC, recruited to the plasma membrane by binding to phosphorylated LAT, hydrolyzes 
phosphoinsositide 4,5 bisphosphate (PI(4,5)P2), leading to generation of inositol triphosphate 
(IP3) and membrane bound diacylglycerol (DAG). IP3 plays a critical role in Ca
2+
 mobilization 
by causing release of Ca
2+
 from the intracellular stores in endoplasmic reticulum (ER) to 
cytoplasm, whereas DAG is involved in the activation of protein kinase C (PKC). Together, Ca
2+
 
mobilization and PKC activation, coupled with further downstream signaling events lead to 
exocytosis of secretory vesicles, which is also known as degranulation. These secretory vesicles 
contain chemical mediators, such as histamine that are responsible for causing allergic reactions 
such as sneezing and itching (11). It has been observed that degranulation occurs within minutes 
after FcεRI bound IgE is crosslinked with the multivalent antigen (12). Although the sequelae of 
biochemical signaling events that take after IgE-FcεRI are aggregated are well characterized, 
until recently not much was known about the interaction of the signaling partners such as Lyn 
with the FcεRI signaling complexes at the plasma membrane.  
 
1.3 Micro-patterned ligands to study spatial regulation of receptor mediated signaling: 
Recently, much interest has focused on understanding the spatiotemporal regulation of 
cell signal transduction. Once the receptor is activated by binding to its ligand, ligand-bound 
receptor interacts with its signaling partners, which may lead to formation of supramolecular 
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complexes of activated receptor with proteins participating in the signaling pathway. One of the 
most important tools to study the localization of proteins is fluorescence microscopy, where 
localization of different proteins may be detected through labeling them with different 
fluorescent dyes. Advances in fluorescent imaging after the development of genetically encoded 
green fluorescent protein (GFP) (13) and the advent of confocal fluorescence microscopy (14) 
allow us to study the sub-cellular localization of proteins. It should be noted, however, that 
fluorescence microscopy was limited by the optical resolution, which is diffraction limited (~250 
nm). With recent advances in the development of sub-optical resolution microscopy techniques – 
stochastic optical reconstruction microscopy (STORM) (15, 16) and photoactivated localization 
microscopy (PALM) (17, 18), the optical resolution has increased significantly (~20 - 40 nm). 
However, morphological heterogeneities and cellular autofluorescence as well as appropriate 
image analysis continue to present challenges.  
The advent of photolithography and modern nanofabrication technology have enabled us 
to manipulate surfaces and substrates at micron and nano scale with high accuracy, a realm that 
was previously inaccessible (19). Together these technologies provide a unique methodology to 
create surfaces for spatially controlled interactions with cells that can be visualized. Features that 
can be generated using photolithography, range from a few nanometers to several micrometers in 
size. For a long time, due to the harsh conditions in the nanofabrication technology, these 
techniques were not very appealing for making biologically-relevant, functionalized surfaces. 
Recent advances, focused on finding biological applications for nanofabricated surfaces 
(reviewed in (3, 20)) led to development of micro/nano-patterned ligand surfaces. These 
fabrication methods utilize a number of techniques including nanocontact printing (21),  
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Figure 1.2: Preparation of micro-patterned surfaces using parylene lift-off method: A) 
Silicon/glass substrates are coated with ~ 1 μm layer of parylene and followed by a 1 μm 
thick layer of photoresist. Photolithography is then carried out with an appropriate mask 
followed by developing and etching to obtain a micro-patterned parylene layer on the 
silicon/glass substrate. Biomaterial (ligand) of interest is then incubated on these substrates 
prior to mechanical lift-off of parylene to obtain a micropatterned ligand surface. B) A 
representative fluorescent image of a micropatterned surface with covalently attached Cy3-
DNP22-BSA. Scale bar: 10 μm. 
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nanoimprint lithography (22), scanning probe lithography (23), microcontact printing (24) and 
polymer lift-off method (25). All of these techniques offer diversity and control over different 
parameters such as the size of features, compatibility with the biomaterial in question, high 
through-put manufacturing and cost effectiveness. Therefore, the choice of technique to be used 
primarily depends on the feature size required and the biomaterial to be utilized. 
The substrates generated using these techniques have been implemented to answer 
previously unsolved biological questions. An interesting example is using these micro-patterned 
surfaces to study cell adhesion mechanisms. Cell adhesion is mediated by the binding of 
integrins, present in the plasma membrane of cells, to proteins in the extracellular matrix (ECM). 
This interaction of cells with the ECM is known to play an important role in cellular processes 
such as cell cycle regulation (26). A pioneering study utilized the micro-patterned fibronectin, an 
ECM protein, to study cell attachment and spreading. The authors found that they could vary the 
extent of cell spreading by varying the size of ECM features, which, in turn, controls important 
cellular processes such as cell growth, proliferation and apoptosis (27).  
Another interesting example involved utilization of micro-patterned substrates to study T-
cell signaling, which is known to operate in immune responses. T cells are activated by 
association with APC (antigen presenting cells) and recognition of foreign peptides displayed by 
major histocompatibility complex (MHC) on the surface of the APC. This interaction of T-cell 
receptor (TCR) with these complexes, along with integrin-mediated interactions, leads to the 
formation of a microscale structure known as the immunological synapse (IS) (28). In one 
particular study, E-beam lithography was used to generate 100 nm wide x 5 nm high chromium 
strips separated by 1 μm spacing on silica substrates (29). Lipid bilayers, containing intercellular 
adhesion molecule 1 (ICAM1) and major histocompatibility complex (MHC) peptides for the 
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activation of TCR, were prepared on these substrates. The authors found that TCR clusters are 
formed within the grid space with distinct orientation towards the center. They also found that 
the phosphorylation state of the TCR, visualized by labeling with anti-phosphotyrosine 
antibodies, depends on the geometrical location of TCR.  
In a separate study, micro-patterned ligands were also utilized to study the interactions of 
aggregated low density lipoproteins (agLDL) with macrophages. Amongst the various functions 
of macrophages in the human body, one of the most medically important functions is their 
interaction with agLDL in the walls of blood vessels. This interaction results in the massive 
uptake of cholesterol and conversion of macrophages to foam cells, which serve as an early step 
in the development of atherosclerosis (30). In this particular study, the authors utilized substrates 
with covalently attached, micro-patterned agLDL. Upon incubating the macrophages on these 
surfaces, they observed regions of low pH at the contact sites. Since the agLDL was covalently 
attached to the substrate, it was concluded that these regions of low pH are extracellular, in 
regions known as the lysosomal synapse (31).  
As illustrated in Figure 1.2, we previously utilized the prepared patterned lipid bilayers, 
consisting of fluorescent lipids for visualization and dinitrophenyl (DNP) conjugated 
phospholipids for binding with anti-DNP-IgE on the surface of RBL-2H3 cells. These micro-
patterned surfaces were prepared using polymer lift-off method described previously (3, 32, 33). 
Figure 1.3A shows the schematic of the RBL-2H3 cells incubated over patterned lipid bilayers 
containing specific ligand. Figure 1.3B demonstrates that Alexa Fluor 488 (A488) tagged IgE co-
localizes with DNP liganded fluorescent patches within a few (~ 5 min) after incubating the cells 
on the patterned surfaces. FcεRI localized over the DNP containing lipid bilayers is tyrosine 
phosphorylated, as detected by anti-phosphotyrosine antibodies (32). Spatial localization of Lyn, 
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was investigated using these micro-patterned ligand surfaces. It was observed that transiently 
transfected Lyn-GFP co-redistributes with the IgE receptor signaling complex on the plasma 
membrane 15 minutes after incubation of the cells (Figure 1.3B). GFP tagged palmitate/myristate 
(PM) acylated region of Lyn, responsible for anchoring of the kinase to plasma membrane, is 
also observed to co-redistribute with patterned ligand patches at the somewhat longer time scale 
(~45 min). However, co-localization of PI(4,5)P2 bound to a specific GFP construct (PH domain 
of PLCδ), or GFP tagged PKC, is not observed with liganded patterned bilayers under similar 
time scales (Wu, Holowka, unpublished results). Fluorescence recovery after photobleaching 
(FRAP) experiments revealed that signaling complexes formed by stimulation with patterned 
lipid bilayers are dynamic in nature (32).  
The role of actin cytoskeleton in FcεRI was also investigated using these micro-patterned 
ligand surfaces. Transiently transfected actin-GFP in RBL-2H3 also co-redistributes over the 
micron sized ligand patches. To further investigate the role of actin cytoskeleton in receptor 
mediated signaling, RBL cells were pretreated with cyotochalasin-D, an inhibitor of actin 
polymerization. This pretreatment with cytochalasin-D prevented the observed accumulation of 
Lyn-GFP, actin-GFP and PM-EGFP (32). In contrast, the same treatment did not reduce the 
accumulation of FcεRI or its tyrosine phosphorylation over the micron sized patches of liganded 
lipid bilayers. This demonstrates that the actin cytoskeleton in stabilizes the macromolecular 
FcεRI signaling complexes formed on the plasma membrane. 
The actin cytoskeleton and other actin binding proteins are known to participate in 
integrin-mediated signaling upon formation of focal adhesions in adherent cells. RBL-2H3 cells 
show enhanced stimulated degranulation when they are adherent to ECM (34), which indicates a 
possibility of crosstalk between the FcεRI and integrin mediated signaling pathways (35).  
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Figure 1.3: Micro-patterned ligands to study FcεRI receptor signaling: A) A schematic 
representing RBL cells with clustered IgE-FcεRI and downstream signaling partners on the 
surface of patterned DNP lipid bilayers. B) A confocal micrograph demonstrating the 
clustering of fluorescently labeled proteins on top of DNP containing lipid bilayers. The 
clustering of A488-IgE, along with localized tyrosine phosphorylation, is observed within 5 
minutes of plating the cells on patterned ligand surfaces, which is significantly faster than 
the clustering Lyn and actin. (Adapted from reference (3)) 
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Studies with patterned ligands have revealed that, in addition to actin-GFP, other cytoskeleton 
interacting proteins such as vinculin, paxillin and talin also co-redistribute with anti-DNP-IgE 
sensitized FcεRI at DNP containing lipid bilayers. However, the GFP construct of integrin α-5, 
one of the most prominent integrins present in RBL-2H3 cells, was found to be excluded from 
the regions of antigen containing lipid bilayers (33). Together, these results demonstrate that 
actin, paxillin, vinculin and talin associate with IgE receptor signaling complexes on the plasma 
membrane independently of integrin association. Biochemical investigations show that paxillin 
knock down alters Ca
2+
 responses in RBL-2H3 cells (32, 33). These studies provided new 
insights regarding the spatial interaction of FcεRI with its signaling partners and the actin 
cytoskeleton.  
 
1.4 FcεRI receptor endocytosis 
Endocytosis is an ubiquitous process utilized by cells to internalize a variety of 
molecules. It is becoming evident that endocytosis plays a key role in regulating important 
cellular processes such as antigen presentation, cell migration and mitosis (36). In addition to 
regulation by phosphatases and kinases, endocytosis is one of the most important pathways that 
lead to down-regulation of receptor mediated signaling responses in immune cells. 
Internalization also leads to degradation of receptors and thereby inhibition of their interactions 
with ligands (37, 38). Interestingly, it has also been determined that receptors in endosomes can 
signal intracellularly, which is different from the signals initiated from the receptors at the 
plasma membrane (39, 40). As schematically depicted in Figure 1.4, receptors can be 
endocytosed by a variety of mechanisms (36, 41, 42). Of the pathways available for receptor 
endocytosis, clathrin mediated pathway has been the most widely studied (42-45), and the 
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clathrin, protein has been known to be involved many intracellular cargo transport processes 
(46). The pathways of endocytosis can be constitutive or can be triggered by a specific signal, as 
in the case of receptor mediated endocytosis, or even hijacked by virus as-to gain entry into the 
cell (47). While a lot of endocytic processes have been traditionally thought of as a clathrin 
dependent processes, recently several clathrin independent endocytic pathways have been 
identified (4, 48). 
Another important component of the endocytic machinery known to play a role in several 
internalization pathways is the GTPase dynamin 2. In model systems this enzyme binds to 
liposomes, and, upon GTP hydrolysis, can stretch and tubulate these liposomes (49). Dynamin 2 
has been implicated in a wide array of internalization processes and is primarily responsible for 
the scission of newly formed vesicles (50). Although clathrin and dynamin are very well 
characterized for their role in endocytosis, there are other players such as adaptor protein 2 (AP2) 
(42), BAR-domain containing proteins (51, 52), ADP-ribosylation factor (Arf) (53) and the Rho 
subfamilies (54) of proteins, that also play important roles in endocytosis. In addition to the role 
of proteins, other components of plasma membrane, such as the phospholipids PI(4,5)P2 (55) and 
cholesterol (56), have been shown to participate in various clathrin-dependent and clathrin-
independent endocytic pathways. The role of the actin cytoskeleton in endocytic pathways has 
been a subject of investigations and it appears that, some, but not all, endocytic pathways depend 
on the actin cytoskeleton. (36, 57). The sensitivity of endocytosis to actin cytoskeleton disruption 
depends on the cell type, identity of endocytic cargo and the endocytic machinery involved.   
In RBL-2H3 cells, the sequelae of signaling events after FcεRI receptor activation via 
crosslinking of IgE has been well established, but less is known about the mechanism of  
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Figure 1.4: Internalization pathways: The schematic represents the various routes 
adopted by a cell for the uptake of different particles. Big particles are engulfed by 
phagocytosis while the fluid uptake is completed in a process known as macropinocytosis. 
Endocytosis for smaller particles (typically < 1 μm) goes primarily through two different 
pathways: clathrin-dependent and clathrin-independent. These endocytic pathways may 
rely on dynamin and/or the actin cytoskeleton depending on the internalization mechanism 
used. (Reproduced from reference (4)) 
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internalization of the FcεRI receptor. Initial evidence demonstrated that RBL-2H3 cells 
expressing FcεRI treated with oligomeric IgE led to internalization of the IgE-FcεRI complexes 
(58), whereas monomeric IgE tended to stay on the plasma membrane for prolonged periods of 
time. Subsequently, it was demonstrated that FcεRI, sensitized with monomeric IgE, were 
internalized upon crosslinking of IgE with a specific antigen (12). It was further determined that 
crosslinked, endocytosed IgE is then trafficked to the lysosomes for degradation (59). These 
authors also demonstrated that internalization of IgE, following its crosslinking, occurred rapidly 
with a t1/2 of 13-19 minutes and, unlike degranulation, it is independent of the presence of 
extracellular Ca
2+. This indicates that crosslinking of FcεRI bound IgE initiates two distinct 
signaling cascades, leading to degranulation and internalization of crosslinked IgE-FcεRI 
complexes, although the relationship between these two signaling pathways is not well 
understood.  
Some studies have investigated the mechanism of FcεRI internalization. Prior evidence 
utilizing flow cytometry and Lyn knock-out mice, demonstrated that FcεRI internalization is 
dependent on Lyn (60), however, the role of Syk kinase in FcεRI internalization has not been 
clearly deliniated. One set of experiments via flow cytometry report robust FcεRI receptor 
internalization in Syk-/- cells (60, 61), whereas others using the same technique have concluded 
that FcεRI receptor internalization is inhibited in Syk-/- cells (62). Previous studies utilizing flow 
cytometry to assess surface accessible IgE have shown that FcεRI internalization is clathrin 
independent (63). However, other studies via electron microscopy showed that clathrin-coated 
pits are colocalized with aggregated FcεRI receptor, suggesting, FcεRI is internalized via clathrin 
mediated endocytosis (64, 65). Over-expression of catalytically inactive dynamin 2 mutant 
(K44A) reduces FcεRI internalization substantially, pointing towards a dependence on dynamin 
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2 for FcεRI internalization (63). Another study has demonstrated that IgE receptor internalization 
is sensitive to cholesterol depletion (62). The role of the actin cytoskeleton in FcεRI endocytosis 
has been elusive, with some studies showing that it is insensitive to disruptions of the actin 
cytoskeleton (66), whereas some studies have shown that it is independent of actin cytoskeleton 
(67).  
In this work, we have utilized fluorescence spectroscopic techniques, flow cytometry and 
confocal microscopy to probe the role of cholesterol, Syk kinase, actin cytoskeleton and dynamin 
2 in FcεRI receptor endocytosis after its crosslinking. We utilize the micro-patterned ligand 
surfaces to study the interplay between dynamin 2 and the actin cytoskeleton at the activated 
FcεRI receptor complexes on the plasma membrane. 
 
1.5 EGFR mediated signaling 
EGFR is part of a broader family of receptor tyrosine kinases (RTKs), that are highly 
conserved in evolution and play an important role in the regulation of cellular processes, such as 
proliferation, migration, differentiation, metabolism and survival (68). Mutations or 
dysregulations in this pathway have been linked to several disorders including cancer, diabetes 
and angiogenesis (69). EGF was first isolated and identified as a growth factor in the 1960’s 
from a serum that accelerated the growth of new born mice (8, 70). Sequence analysis of EGF 
revealed that it is a small peptide with 53 amino acids and 6 cysteine residues, known to form 
three disulfide bonds, which are critical for EGF activity (71). EGFR was later identified to be a 
transmembrane glycoprotein, which possesses intrinsic tyrosine kinase activity, stimulated by 
binding to EGF. The EGFR consists of an extracellular ligand binding domain, a single  
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Figure 1.5: Schematic of signaling pathway activated by EGFR: The EGFR signaling 
pathway is initiated upon binding of EGF to EGFR on the surface of the cells, leading to 
dimerization of EGFR and activation of its tyrosine kinase activity. The tyrosine 
phosphorylated residues on the cytoplasmic tail of EGFR act as docking sites for its 
signaling partners. EGFR activation leads to activation of Erk via the Ras, Raf, MEK 
pathway and the activation of mTor via the PI3K-Akt pathway. These pathways are critical 
in controlling cellular responses such as growth, proliferation, and apoptosis. (Reproduced 
from reference (2)) 
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transmembrane domain and a cytoplasmic domain (72, 73). EGF binding to the extracellular 
domain of EGFR (ErbB1), causes a conformational change, leading to the exposure of the 
dimerization arm in the cytoplasmic domain (74, 75). This leads to the formation of EGFR 
homodimers and/or heterodimers with other members of EGFR family, ErbB2, ErbB3 and 
ErbB4 (76). The intracellular portion of the EGFR includes a polybasic juxtamembrane region, 
the tyrosine kinase domain, and a carboxy terminal regulatory region. Tyrosine kinase residues 
in the carboxy terminal region are not phosphorylated in the monomeric state of EGFR (77). 
EGF-induced dimerization of EGFR, causes the transphosphorylation of tyrosine residues which 
act as docking sites for several SH2 domain-containing proteins (78). Additionally, the tyrosine 
kinase domain of the EGFR can phosphorylate tyrosine residues on other signaling partners, such 
as phospholipase Cγ (PLCγ) (79) and cytoskeleton-associated proteins such as α-actinin (80). 
Apart from tyrosine residues phosphorylated by EGFR kinase, other residues on the EGF 
receptor intracellular segments can be phosphorylated by other kinases, which are activated as 
result of EGFR activation. Examples of residues that are phosphorylated by a non EGFR kinase 
include the phosphorylation of Tyr-845 by tyrosine kinase Src (81) and Thr-654 by protein 
kinase C (PKC) (82).   
EGFR tyrosine phosphorylated residues act as sites for the recruitment of adaptor protein 
2 (Grb2), which binds to the son of sevenless (SOS) protein (83). SOS is the guanine nucleotide 
exchange factor (GEF) that is required for the activation of Ras, a GTPase and a potent 
oncoprotein (84, 85). GTP-bound Ras then activates and phosphorylates its effector kinase, Raf.  
Activated Raf is responsible for the activation of mitogen-extracellular activated protein kinase 
kinase-I (MEK), which in turn phosphorylates extracellular regulated kinase (ERK) (86). ERK 
has numerous downstream and upstream substrates, which further explains how dysregulation of 
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ERK signaling pathway has such profound effects on cell growth (87). In addition to the 
activation of the Ras/Raf/MEK/Erk pathway, as described in Figure 1.5, EGFR also activates 
several other critical signaling pathways including the phosphatidylinositol 3-kinase (PI3K)/Akt 
pathway (88) and the signal transducers and activators of transcription (STAT) pathway (89). 
Altogether, these pathways are responsible for key cellular processes like migration, division and 
proliferation. Dysregulation of any one of these pathways has often been implicated in causing 
cancer (69, 90).   
Although much work has been done to study the series of signaling events that take place 
upon the EGFR activation, not much is known about the spatial regulation of signaling partners 
like Ras, MEK and ERK with EGFR in the cells. Previous results have shown the association of 
signaling partners such as Grb2 and PLCγ with the EGFR via immunoprecipitations (IP) (79, 
83). However, visualization of the signaling complexes formed with the EGF receptor is 
governed by the limitations in fluorescence microscopy and receptor internalization.  
In this work, we utilize silicon substrates patterned with immobilized, covalently attached 
micron sized EGF patches to stimulate the EGFR. This stimulation results in the formation of 
macromolecular signaling complexes of EGF receptor, which are localized at the plasma 
membrane. We then study the recruitment of the EGFR signaling partners utilizing confocal 
fluorescent microscope.   
 
1.6 Role of PI(4,5)P2 in cell signaling 
Phosphoinositides (PI) comprise some of the most functionally important lipids of the 
inner leaflet of the plasma membrane. PI(4,5)P2 is one of the most widely studied phospholipids 
due to the role it plays in cellular signaling (91). Initially, PI(4,5)P2 was considered to be an 
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important precursor in signaling because it led to the formation of secondary messengers IP3 and 
DAG upon hydrolysis by PLC (92). Subsequently, it was discovered that PI(4,5)P2 can directly 
affect signaling by interacting with signaling proteins and actin cytoskeleton-regulating proteins 
such as profilactin (93). PI(4,5)P2 can also be phosphorylated by phosphatidylinositol 3-kinase 
(PI3K) leading to the formation of PI(3,4,5)P3, which is important for a variety of cellular 
processes including proliferation, migration, differentiation and phagocytosis (94). In addition, 
PI(4,5)P2 has also been implicated in controlling important cellular processes such as 
endocytosis, vesicular trafficking, membrane dynamics and activation of ion channels (91, 94).  
Together, PI(4,5)P2 and PI(3,4,5)P3 comprise 1% of total plasma membrane lipid content 
and they require constant replenishment. PI(4,5)P2 may be synthesized by phosphorylation of 
phosphatidylinositol 4-phosphate (PI(4)P) via phosphatidylinositol 5-kinase (PI5K), or by 
phosphorylation of phosphatidylinositol 5-phosphate (PI(5)P) via phosphatidylinositol 4-kinase 
(PI4K). Since PI(4)P is much more concentrated in cells in comparison to PI(5)P, it has been 
generally accepted that the majority of PI(4,5)P2 is derived from the phosphorylation of PI(4)P 
by PI5K (91). Interfering with PI(4,5)P2 concentrations by pharmacological treatments or by 
expression of dominant negative versions of PI4K/PI5K has profound effects on cellular 
physiology (94).  
Hydrolysis of PI(4,5)P2 by PLC into IP3 and DAG has already been implicated in Ca
2+
 
mobilization and activation of PKC respectively. Ca
2+
 mobilization and activation of PKC are 
both essential for the stimulated exocytosis in RBL cells. Previous studies done by inhibition of 
PI4K by the pharmacological inhibitors phenylarsinoxide (PAO) and quercetin in RBL-2H3 cells 
have shown that they affect Ca
2+
 mobilization and inhibit degranulation (95). Although, the role 
of PI(4,5)P2 in degranulation has been widely studied, its role in FcεRI endocytosis has not been 
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very well understood. Some previous experiments, utilizing acid stripping method in RBL cells 
have demonstrated that interfering with PI(4,5)P2 synthesis by treatment with quercetin does not 
inhibit crosslinked IgE internalization (66). Given the role of P(4,5)P2 in endocytosis and the 
regulation of endocytic proteins such as AP-2, epsin and dynamin 2, it is of considerable interest 
to study the effects of PI(4,5)P2 on FcεRI internalization (96). 
The role of PI(4,5)P2 in EGFR signaling, leading to the activation of downstream targets 
such as ERK, as well as EGFR endocytosis, has not been established. EGFR has a polybasic 
juxtamembrane domain, and it is predicted that negatively charged PI(4,5)P2 binds to the 
positively charged residues in the juxtamembrane domain to maintain the EGFR kinase in an 
inactive state (97). Consistent with this, it has been shown that up-regulation of PI(4,5)P2 levels 
results in lower EGF stimulated tyrosine phosphorylation of EGFR, whereas down-regulation of 
PI(4,5)P2 leads to enhanced tyrosine phosphorylation of EGFR upon stimulation with EGF (98). 
This evidence indicates that EGFR activation is tightly regulated by the PI(4,5)P2 levels in the 
inner leaflet of the plasma membrane. PI(4,5)P2 turnover is also critical in EGF receptor 
signaling, as the hydrolysis of PI(4,5)P2 by PLC leads to formation of IP3 and DAG, which are 
important in calcium mobilization and PKC activation and further mediate downstream 
responses. PI3K phosphorylation of PI(4,5)P2 to generate PI(3,4,5)P3, which is responsible for 
regulation of various signaling pathways including the activation of Akt/mTor. PI(3,4,5)P3 also 
interacts with GEFs that are responsible for regulation of cellular processes such as proliferation, 
migration and differentiation (99).   
EGFR is thought to be endocytosed by both clathrin-dependent and clathrin-independent 
pathways (100). As previously mentioned, PI(4,5)P2 plays an important role in these pathways 
by regulation of endocytic proteins, and thus may play an important role in EGFR endocytosis. 
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Despite the significance of PI(4,5)P2 in the regulation of EGFR signaling and EGFR endocytosis, 
not much is known about the spatial localization of PI(4,5)P2 with respect to the EGFR signaling 
complex on the plasma membrane.   
 
1.7 Scope of thesis: 
As described in this dissertation, I have used a myriad of cell biological approaches to 
study the spatial regulation of cell signaling following receptor activation. In Chapter 2, I have 
examined endocytosis utilizing flow cytometry, fluorescence spectroscopy and confocal 
microscopy to determine the localization of crosslinked FcεRI bound to IgE. I determined that in 
the presence of inhibitors of F-actin cycling, crosslinked IgE is in membrane invaginations which 
are not cleaved from the plasma membrane. Utilization of micro-patterned ligands demonstrated 
that dynamin 2 plays a role in the organization of the actin cytoskeleton at the sites of clustered 
IgE-FcεRI. Both internalization of FcεRI and recruitment of F-actin to micro-patterned surfaces 
are inhibited in presence of pharmacological inhibitors of PI(4,5)P2 synthesis.  
In Chapter 3, I demonstrate that micro-patterned arrays of covalently conjugated EGF can 
activate EGFR on the surface of NIH-3T3 cells. I utilized these micro-patterned EGF surfaces to 
observe that EGFR signaling partners including PLCγ, Ras, MEK and ERK co-redistribute with 
EGFR signaling complexes on the plasma membrane in a ligand and cytoskeleton dependent 
manner. F-actin and paxillin are also recruited to the EGFR signaling complexes on the plasma 
membrane. This recruitment of signaling partners to the micron sized patches of EGF via EGFR 
is independent of integrin α-5, the most abundant integrin expressed in NIH-3T3 cells. 
Moreover, this recruitment of signaling partners such as Ras and Erk, F-actin depends on 
PI(4,5)P2 synthesis.  
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Collectively, these results demonstrate that fluorescence confocal microscopy and micro-
patterned ligand arrays can be utilized to study the spatial localization of signaling partners in 
ligand activated receptor mediated signaling pathways. These immobilized ligands on the 
surfaces activate the receptor signaling, but prevent their internalization without pharmacological 
inhibition. These techniques provide a novel opportunity to study the orchestrated accumulation 
of biomolecules involved in cell signaling and endocytosis.   
  
28 
 
References: 
 
1. Luisi PL. About various definitions of life. Origins of Life and Evolution of 
Biospheres.1998;28:613-622. 
2. Pines G, Köstler WJ, Yarden Y. Oncogenic mutant forms of EGFR: Lessons in signal 
transduction and targets for cancer therapy. FEBS letters.2010;584:2699-2706. 
3. Torres AJ, Wu M, Holowka D, Baird B. Nanobiotechnology and cell biology: micro- and 
nanofabricated surfaces to investigate receptor-mediated signaling. Annu Rev 
Biophys.2008;37:265-288. 
4. Mayor S, Pagano RE. Pathways of clathrin-independent endocytosis. Nat Rev Mol Cell 
Biol.2007;8:603-612. 
5. Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J. Molecular cell 
biology. New York.1995. 
6. Hardie DG. Biochemical messengers: hormones, neurotransmitters, and growth factors. 
Springer, 1991. 
7. Beaven MA. Our perception of the mast cell from Paul Ehrlich to now. European journal 
of immunology.2009;39:11-25. 
8. Edwin F, et al. A historical perspective of the EGF receptor and related systems. 
METHODS IN MOLECULAR BIOLOGY-CLIFTON THEN TOTOWA-.2006;327:1. 
9. Holowka D, Baird B. Antigen-mediated IgE receptor aggregation and signaling: a 
window on cell surface structure and dynamics. Annual review of biophysics and biomolecular 
structure.1996;25:79-112. 
10. Young RM, Holowka D, Baird B. A lipid raft environment enhances Lyn kinase activity 
by protecting the active site tyrosine from dephosphorylation. Journal of Biological 
Chemistry.2003;278:20746-20752. 
11. Kinet JP. The high-affinity IgE receptor (FcεRI): from physiology to pathology. Annual 
review of immunology.1999;17:931-972. 
12. Furuichi K, Rivera J, Isersky C. The fate of IgE bound to rat basophilic leukemia cells. 
III. Relationship between antigen-induced endocytosis and serotonin release. The Journal of 
Immunology.1984;133:1513-1520. 
29 
 
13. Shimomura O, Johnson FH, Saiga Y. Extraction, purification and properties of aequorin, 
a bioluminescent protein from the luminous hydromedusan, Aequorea. Journal of cellular and 
comparative physiology.1962;59:223-239. 
14. White J, Amos W, Fordham M. An evaluation of confocal versus conventional imaging 
of biological structures by fluorescence light microscopy. The Journal of cell 
biology.1987;105:41-48. 
15. Rust MJ, Bates M, Zhuang X. Sub-diffraction-limit imaging by stochastic optical 
reconstruction microscopy (STORM). Nature methods.2006;3:793-796. 
16. Huang B, Wang W, Bates M, Zhuang X. Three-dimensional super-resolution imaging by 
stochastic optical reconstruction microscopy. Science.2008;319:810-813. 
17. Betzig E, et al. Imaging intracellular fluorescent proteins at nanometer resolution. 
Science.2006;313:1642-1645. 
18. Hess ST, Girirajan TPK, Mason MD. Ultra-high resolution imaging by fluorescence 
photoactivation localization microscopy. Biophysical journal.2006;91:4258-4272. 
19. Campbell SA. The science and engineering of microelectronic fabrication. Oxford 
University Press Oxford, UK, 1996. 
20. Voldman J, Gray ML, Schmidt MA. Microfabrication in biology and medicine. Annual 
review of biomedical engineering.1999;1:401-425. 
21. Odom TW, Thalladi VR, Love JC, Whitesides GM. Generation of 30-50 nm structures 
using easily fabricated, composite PDMS masks. Journal of the American Chemical 
Society.2002;124:12112-12113. 
22. Falconnet D, et al. A novel approach to produce protein nanopatterns by combining 
nanoimprint lithography and molecular self-assembly. Nano Letters.2004;4:1909-1914. 
23. Agarwal G, Naik RR, Stone MO. Immobilization of histidine-tagged proteins on nickel 
by electrochemical dip pen nanolithography. Journal of the American Chemical 
Society.2003;125:7408-7412. 
24. Quist AP, Pavlovic E, Oscarsson S. Recent advances in microcontact printing. Analytical 
and bioanalytical chemistry.2005;381:591-600. 
25. Ilic B, Craighead H. Topographical patterning of chemically sensitive biological 
materials using a polymer-based dry lift off. Biomedical Microdevices.2000;2:317-322. 
30 
 
26. Bijian K, Takano T, Papillon J, Khadir A, Cybulsky AV. Extracellular matrix regulates 
glomerular epithelial cell survival and proliferation. American Journal of Physiology-Renal 
Physiology.2004;286:F255-F266. 
27. Chen CS, Mrksich M, Huang S, Whitesides GM, Ingber DE. Geometric control of cell 
life and death. Science.1997;276:1425-1428. 
28. Bromley SK, et al. The immunological synapse. Annual review of 
immunology.2001;19:375-396. 
29. Mossman KD, Campi G, Groves JT, Dustin ML. Altered TCR signaling from 
geometrically repatterned immunological synapses. Science's STKE.2005;310:1191. 
30. Maxfield FR, Tabas I. Role of cholesterol and lipid organization in disease. 
Nature.2005;438:612-621. 
31. Haka AS, et al. Macrophages create an acidic extracellular hydrolytic compartment to 
digest aggregated lipoproteins. Molecular biology of the cell.2009;20:4932-4940. 
32. Wu M, Holowka D, Craighead HG, Baird B. Visualization of plasma membrane 
compartmentalization with patterned lipid bilayers. Proc Natl Acad Sci U S A.2004;101:13798-
13803. 
33. Torres AJ, Vasudevan L, Holowka D, Baird BA. Focal adhesion proteins connect IgE 
receptors to the cytoskeleton as revealed by micropatterned ligand arrays. Proc Natl Acad Sci U 
S A.2008;105:17238-17244. 
34. Hamawy MM, Oliver C, Mergenhagen SE, Siraganian RP. Adherence of rat basophilic 
leukemia (RBL-2H3) cells to fibronectin-coated surfaces enhances secretion. The Journal of 
Immunology.1992;149:615-621. 
35. Ra C, Yasuda M, Yagita H, Okumura K. Fibronectin receptor integrins are involved in 
mast cell activation. Journal of allergy and clinical immunology.1994;94:625-628. 
36. Doherty GJ, McMahon HT. Mechanisms of endocytosis. Annual review of 
biochemistry.2009;78:857-902. 
37. Cheng PC, Steele CR, Gu L, Song W, Pierce SK. MHC class II antigen processing in B 
cells: accelerated intracellular targeting of antigens. The Journal of Immunology.1999;162:7171. 
38. Liu H, Rhodes M, Wiest DL, Vignali DAA. On the dynamics of TCR: CD3 complex cell 
surface expression and downmodulation. Immunity.2000;13:665-675. 
31 
 
39. McPherson PS, Kay BK, Hussain NK. Signaling on the endocytic pathway. 
Traffic.2001;2:375-384. 
40. Hoeller D, Volarevic S, Dikic I. Compartmentalization of growth factor receptor 
signalling. Current opinion in cell biology.2005;17:107-111. 
41. Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature.2003;422:37-44. 
42. Sorkin A. Cargo recognition during clathrin-mediated endocytosis: a team effort. Current 
opinion in cell biology.2004;16:392-399. 
43. Robinson MS. The role of clathrin, adaptors and dynamin in endocytosis. Current opinion 
in cell biology.1994;6:538-544. 
44. Schmid EM, McMahon HT. Integrating molecular and network biology to decode 
endocytosis. Nature.2007;448:883-888. 
45. Mousavi SA, Malerød L, Berg T, Kjeken R. Clathrin-dependent endocytosis. 
Biochemical Journal.2004;377:1. 
46. Kirchhausen T. Clathrin. Annual review of biochemistry.2000;69:699-727. 
47. Marsh M, Helenius A. Virus entry: open sesame. Cell.2006;124:729-740. 
48. Kirkham M, Parton RG. Clathrin-independent endocytosis: new insights into caveolae 
and non-caveolar lipid raft carriers. Biochimica et Biophysica Acta (BBA)-Molecular Cell 
Research.2005;1745:273-286. 
49. Stowell M, Marks B, Wigge P, McMahon HT. Nucleotide-dependent conformational 
changes in dynamin: evidence for a mechanochemical molecular spring. Nat Cell 
Biol.1999;1:27-32. 
50. Hinshaw J. Dynamin and Its Role in Membrane Fission 1. Annual review of cell and 
developmental biology.2000;16:483-519. 
51. David C, McPherson PS, Mundigl O, De Camilli P. A role of amphiphysin in synaptic 
vesicle endocytosis suggested by its binding to dynamin in nerve terminals. Proceedings of the 
National Academy of Sciences.1996;93:331. 
52. McPherson VA, et al. Contributions of F-BAR and SH2 Domains of Fes Protein Tyrosine 
Kinase for Coupling to the FcεRI Pathway in Mast Cells. Molecular and cellular 
biology.2009;29:389-401. 
53. Donaldson JG, Klausner RD. ARF: a key regulatory switch in membrane traffic and 
organelle structure. Current opinion in cell biology.1994;6:527-532. 
32 
 
54. Ellis S, Mellor H. Regulation of endocytic traffic by rho family GTPases. Trends in cell 
biology.2000;10:85-88. 
55. Haucke V. Phosphoinositide regulation of clathrin-mediated endocytosis. Biochemical 
Society Transactions.2005;33:1285. 
56. Nabi IR, Le PU. Caveolae/raft-dependent endocytosis. The Journal of cell 
biology.2003;161:673-677. 
57. Fujimoto LM, Roth R, Heuser JE, Schmid SL. Actin assembly plays a variable, but not 
obligatory role in receptor-mediated endocytosis in mammalian cells. Traffic.2000;1:161-171. 
58. Isersky C, Rivera J, Segal D, Triche T. The fate of IgE bound to rat basophilic leukemia 
cells. II. Endocytosis of IgE oligomers and effect on receptor turnover. The Journal of 
Immunology.1983;131:388-396. 
59. Furuichi K, Rivera J, Buonocore LM, Isersky C. Recycling of receptor-bound IgE by rat 
basophilic leukemia cells. The Journal of Immunology.1986;136:1015-1022. 
60. Kitaura J, Xiao W, Maeda-Yamamoto M, Kawakami Y, Lowell CA, Kawakami T. Early 
divergence of Fc epsilon receptor I signals for receptor up-regulation and internalization from 
degranulation, cytokine production, and survival. J Immunol.2004;173:4317-4323. 
61. Fattakhova GV, et al. Endosomal trafficking of the ligated FcvarepsilonRI receptor. Mol 
Immunol.2009;46:793-802. 
62. Molfetta R, et al. Lipid raft-dependent FcepsilonRI ubiquitination regulates receptor 
endocytosis through the action of ubiquitin binding adaptors. PLoS One.2009;4:e5604. 
63. Fattakhova G, Masilamani M, Borrego F, Gilfillan AM, Metcalfe DD, Coligan JE. The 
high-affinity immunoglobulin-E receptor (FcepsilonRI) is endocytosed by an AP-2/clathrin-
independent, dynamin-dependent mechanism. Traffic.2006;7:673-685. 
64. Wilson BS, Pfeiffer JR, Oliver JM. Observing FcεRI signaling from the inside of the 
mast cell membrane. The Journal of cell biology.2000;149:1131-1142. 
65. Burns AR, Oliver JM, Pfeiffer JR, Wilson BS. Visualizing Clathrin-Mediated IgE 
Receptor Internalization by Electron and Atomic Force Microscopy. METHODS IN 
MOLECULAR BIOLOGY-CLIFTON THEN TOTOWA-.2008;440:235. 
66. Furuichi K, Ra C, Isersky C, Rivera J. Comparative evaluation of the effect of 
pharmacological agents on endocytosis and coendocytosis of IgE by rat basophilic leukaemia 
cells. Immunology.1986;58:105-110. 
33 
 
67. Ra C, Furuichi K, Rivera J, Mullins JM, Isersky C, White KN. Internalization of IgE 
receptors on rat basophilic leukemic cells by phorbol ester. Comparison with endocytosis 
induced by receptor aggregation. Eur J Immunol.1989;19:1771-1777. 
68. Lemmon MA, Schlessinger J. Cell signaling by receptor tyrosine kinases. 
Cell.2010;141:1117-1134. 
69. Gschwind A, Fischer OM, Ullrich A. The discovery of receptor tyrosine kinases: targets 
for cancer therapy. Nature Reviews Cancer.2004;4:361-370. 
70. Cohen S. The stimulation of epidermal proliferation by a specific protein (EGF). 
Developmental biology.1965;12:394-407. 
71. Savage Jr CR, Inagami T, Cohen S. The primary structure of epidermal growth factor. 
Journal of Biological Chemistry.1972;247:7612-7621. 
72. Carpenter G, Lembach KJ, Morrison M, Cohen S. Characterization of the binding of 125-
I-labeled epidermal growth factor to human fibroblasts. Journal of Biological 
Chemistry.1975;250:4297-4304. 
73. Cohen S, Ushiro H, Stoscheck C, Chinkers M. A native 170,000 epidermal growth factor 
receptor-kinase complex from shed plasma membrane vesicles. Journal of Biological 
Chemistry.1982;257:1523. 
74. Burgess AW, et al. An open-and-shut case? Recent insights into the activation of 
EGF/ErbB receptors. Molecular cell.2003;12:541-552. 
75. Bouyain S, Longo PA, Li S, Ferguson KM, Leahy DJ. The extracellular region of ErbB4 
adopts a tethered conformation in the absence of ligand. Proceedings of the National Academy of 
Sciences of the United States of America.2005;102:15024. 
76. Leahy DJ. Structure and Function of the Epidermal Growth Factor (EGF⧸ ErbB) Family 
of Receptors. Advances in protein chemistry.2004;68:1-27. 
77. Stamos J, Sliwkowski MX, Eigenbrot C. Structure of the epidermal growth factor 
receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. Journal of 
Biological Chemistry.2002;277:46265. 
78. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell 
Biol.2001;2:127-137. 
79. Margolis B, et al. EGF induces tyrosine phosphorylation of phospholipase C-II: a 
potential mechanism for EGF receptor signaling. Cell.1989;57:1101. 
34 
 
80. Akiyama T, et al. Substrate specificities of tyrosine-specific protein kinases toward 
cytoskeletal proteins in vitro. Journal of Biological Chemistry.1986;261:14797-14803. 
81. Sato KI, Sato A, Aoto M, Fukami Y. c-Src phosphorylates epidermal growth factor 
receptor on tyrosine 845. Biochemical and biophysical research communications.1995;215:1078-
1087. 
82. Hunter T, Ling N, Cooper JA. Protein kinase C phosphorylation of the EGF receptor at a 
threonine residue close to the cytoplasmic face of the plasma membrane. Nature.1984;311:480-
483. 
83. Rozakis-Adcock M, Fernley R, Wade J, Pawson T, Bowtell D. The SH2 and SH3 
domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1.1993. 
84. Wolfman A, Macara IG. A cytosolic protein catalyzes the release of GDP from p21ras. 
Science.1990;248:67-69. 
85. Downward J, Riehl R, Wu L, Weinberg RA. Identification of a nucleotide exchange-
promoting activity for p21ras. Proceedings of the National Academy of Sciences.1990;87:5998. 
86. Marshall C. Specificity of receptor tyrosine kinase signaling: transient versus sustained 
extracellular signal-regulated kinase activation. Cell.1995;80:179. 
87. Ramos JW. The regulation of extracellular signal-regulated kinase (ERK) in mammalian 
cells. The international journal of biochemistry & cell biology.2008;40:2707-2719. 
88. Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase–AKT pathway in human 
cancer. Nature Reviews Cancer.2002;2:489-501. 
89. Bromberg J. Stat proteins and oncogenesis. Journal of Clinical 
Investigation.2002;109:1139-1142. 
90. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. 
Cell.1990;61:203-212. 
91. Di Paolo G, De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. 
Nature.2006;443:651-657. 
92. Berridge MJ, Irvine RF. Inositol phosphates and cell signalling.1989. 
93. Yin HL, Janmey PA. Phosphoinositide regulation of the actin cytoskeleton. Annual 
review of physiology.2003;65:761-789. 
94. Czech MP. PIP2 and PIP3: Complex Roles Minireview at the Cell Surface. 
Cell.2000;100:603-606. 
35 
 
95. Marcela de Souza Santos RMZGN, David Holowka and Barbara Baird. Inhibitors of 
PI(4,5)P2 Synthesis Reveal Dynamic Regulation of IgE Receptor Signaling by 
Phosphoinositides in Mast Cells. Journal of cell science.2012;Submitted. 
96. Wenk MR, De Camilli P. Protein-lipid interactions and phosphoinositide metabolism in 
membrane traffic: insights from vesicle recycling in nerve terminals. Proceedings of the National 
Academy of Sciences of the United States of America.2004;101:8262. 
97. McLaughlin S, Smith SO, Hayman MJ, Murray D. An electrostatic engine model for 
autoinhibition and activation of the epidermal growth factor receptor (EGFR/ErbB) family. The 
Journal of general physiology.2005;126:41-53. 
98. Michailidis IE, et al. Phosphatidylinositol-4, 5-bisphosphate regulates epidermal growth 
factor receptor activation. Pflügers Archiv European Journal of Physiology.2011;461:387-397. 
99. Cantley LC. The phosphoinositide 3-kinase pathway. Science's STKE.2002;296:1655. 
100. Sorkin A, Goh LK. Endocytosis and intracellular trafficking of ErbBs. Experimental cell 
research.2009;315:683-696. 
 
 
36 
 
Chapter 2
1
 
Investigating the interplay of dynamin and the actin cytoskeleton in FcεRI 
receptor internalization 
2.1 Introduction 
FcεRI, the high affinity receptor for immunoglobulin E (IgE), is a member of the cell 
surface family of multichain immune receptors that are activated by receptor aggregation and 
thereby induce phosphorylation of immunoreceptor tyrosine-based activation motifs (ITAMs) by 
Src family kinases (3, 4). FcεRI is mostly found on the surface of mast cells and basophils and is 
sensitized to stimulation by specific antigens by binding of IgE. Upon crosslinking by 
multivalent ligands (antigen), IgE-FcεRI mediate signaling events that lead to release of 
chemical mediators that cause inflammatory responses in allergic reactions (6, 7). Clustering of 
IgE-FcεRI complexes on the surface of the mast cells initiates a cascade of signaling events 
leading to multiple cellular responses including, but not limited to, cell spreading, ruffling, 
cytokine production and secretion, as well as exocytosis of chemical mediators (degranulation), 
and endocytosis of the aggregated IgE-FcεRI complexes. Although signaling steps leading to 
release of chemical mediators have been extensively characterized (4, 8), less is known about the 
role of signaling in receptor internalization after crosslinking by antigen.  
Signaling responses in mast cells are regulated not only by kinases and phosphatases, but 
also by cell surface receptor expression and internalization that occurs after receptor aggregation 
(9, 10). Although there is some evidence for early divergence of pathways leading to IgE-FcεRI 
internalization and degranulation (11), the relationship between these two pathways is 
incompletely understood. Some recent investigations have focused on FcεRI internalization (11-
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 Alexis J. Torres performed the protein knockdown experiments and dynamin localization to micro-patterned ligand 
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13), but the mechanism of the endocytosis of antigen crosslinked IgE-FcεRI complexes is not 
completely understood. Cell surface receptors can be endocytosed by a variety of mechanisms, 
and redundancy can exist such that endocytosis can be regulated by more than one signaling 
pathway (14).  
Of all the available pathways for receptor internalization, clathrin mediated endocytosis 
has been best characterized. Recently, it has become more evident that many types of receptors 
can be endocytosed by clathrin-independent mechanisms (15). Cytokine receptors have been 
shown to be internalized via a clathrin-independent, cortactin/dynamin-dependent mechanism 
(16). Previous studies have provided evidence that FcεRI internalization is clathrin-dependent by 
virtue of colocalization of IgE-FcεRI complexes with clathrin-coated pits using electron 
microscopy (17, 18). In contrast, other studies using siRNA to knock down clathrin have shown 
that IgE receptor internalization is clathrin/AP-2 independent (12). These studies also 
demonstrated that IgE internalization is dynamin 2-dependent, as the over-expression of 
dominant negative, catalytically inactive dynamin 2 substantially reduced the IgE internalization. 
Furthermore, the role of the actin cytoskeleton in internalization of FcεRI remains to be defined, 
as there are some pathways that are actin-independent (19) and some that are actin-dependent 
(20). Dynamin 2 has been implicated in clathrin-independent, as well as clathrin-dependent 
receptor internalization (16, 21). PI(4,5)P2, a phospholipid that is implicated in a variety of 
signaling processes, has been known to play a role in targeting the actin cytoskeleton to the sites 
of endocytosis on the plasma membrane (20, 22).  
FcεRI-IgE complexes upon crosslinking are known to be stabilized in specialized ordered 
membrane domains enriched in cholesterol and sphingolipid, commonly called lipid rafts, where 
they couple with a Src family kinase, Lyn, to initiate signal transduction (23-25). Some evidence 
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shows that glycosyl-phosphatidylinositol (GPI) anchored proteins can be internalized by a 
clathrin-independent, lipid raft-dependent mechanism (26). Prior results have shown that 
crosslinked FcεRI internalization is sensitive to cholesterol depletion by methyl-β-cyclodextrin 
(MβCD) pretreatment (27). In addition, it has been demonstrated that IgE-sensitized RBL cells 
show different degranulation and signaling responses when stimulated by bivalent and trivalent 
ligands with different geometrical constraints (28). Prior experiments have shown that 
stimulating the cells with anti-FcεRI antibodies can cause internalization of IgE receptors (29). 
However, not much is known about the relationship between internalization and degree of 
crosslinking of IgE receptors.   
Previous studies have utilized flow cytometry as a method to measure the extent of IgE 
receptor internalization (12, 27), but the method can be ambiguous. Here, we monitor the 
fluorescence quenching of FITC-IgE due to acidification of internalized FITC-IgE and also flow 
cytometry to assess the surface accessibility of IgE-FcεRI complexes. We find that in presence of 
inhibitors of F-actin polymerization, crosslinked IgE-FcεRI complexes are in membrane 
invaginations that are not detected via surface-accessible antibody labeling by flow cytometry, 
but are not pinched off from the plasma membrane to become internalized, as revealed by 
sensitivity to extracellular pH. We also demonstrate that the internalization of IgE receptors is 
sensitive to mild cholesterol depletion. Using siRNA to selectively knock down clathrin, 
dynamin, and cortactin, we find that IgE internalization does not depend on clathrin or cortactin, 
but depends on dynamin 2. We further utilize micropatterned ligand surfaces to show that 
dynamin-2 is recruited to clustered, activated FcεRI and plays a role in the consequent 
organization of the actin cytoskeleton. We also provide evidence that in PI(4,5)P2 synthesis is 
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important for recruitment of F-actin to the activated FcεRI receptors and their subsequent 
internalization.    
  
2.2 Materials and Methods 
2.2.1 Materials:  
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 1,2-dipalmitoyl-sn-
glycero-3-phosphoethanolamine-N-[6-[(2,4-dinitrophenyl)amino]hexanoyl] (DNP-cap-PE) were 
purchased from Avanti Polar Lipids. Mouse monoclonal anti-DNP IgE was purified as described 
elsewhere (30) and conjugated to Alexa Fluor 488 (Invitrogen) or fluorescein isothiocyanate 
(FITC) as described previously (31). Alexa 568-labeled goat anti-mouse IgG1, Alexa 568-labeled 
goat anti-rabbit (H+L), Alexa 568-labeled phalloidin, anti-Alexa 488 rabbit IgG, and Alexa 647-
labeled goat anti rabbit IgG were purchased from Invitrogen. Mouse anti-dynamin 1 (clone 41) 
and mouse anti-clathrin heavy chain (clone 23) were purchased from BD Biosciences. Polyclonal 
anti-dynamin 2 (raised against a synthetic peptide corresponding to residues 760-779 from 
human dynamin 2) was purchased from Abcam. Mouse anti-cortactin (clone 4F11) was 
purchased from Millipore, rabbit anti-HS1 (rodent specific) was from Cell Signaling 
Technologies, monoclonal anti-α-tubulin (clone N.593) was from U.S. Biologicals, and human 
IgG was from Jackson Immunoresearch. Mouse anti-clathrin heavy chain (X-22) was a gift from 
Dr. Frances Brodsky (University of California, San Francisco). Dynamin 2-EGFP (32) and 
Dynamin 2 K44A –EGFP (32)  cDNA were gifts from Dr. Mark McNiven (Mayo Clinic). 
Cytochalasin D was purchased from Calbiochem (EMD Chemicals). 3-methacryloxypropyl 
tris(trimethylsiloxy)silane (MPTS) was purchased from Fluka.  
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2.2.2 Cell Culture and Transfection : 
RBL-2H3 cells were maintained in monolayer cultures and harvested with trypsin-EDTA 
(Invitrogen) 3–5 days after passage, as described previously (30). For internalization experiments 
by measuring IgE acidification, cells were sensitized for 1 h at 37°C with FITC-IgE prior to 
fluorescence measurements, and excess IgE was removed by three consecutive steps of 
centrifugation and resuspension in buffered saline solution (BSS: 135 mM NaCl, 5.0 mM KCl, 
1.8 mM CaCl2, 1.0 mM MgCl2, 5.6 mM glucose and 20 mM Hepes, pH 7.4). In other 
experiments, cells were sensitized overnight with unlabeled or Alexa 488-labeled IgE.  In 
experiments involving chemical inhibitors, cells were incubated with specified agents at 37°C for 
2-5 min before and during the time of the measurement. Cells were transfected with specified 
EGFP constructs in a Gene Pulser Xcell electroporator system (Bio-Rad) as follows: Cells 
(10
7
/ml) resuspended in buffer [137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, 5.6 mM glucose, 20 
mM Hepes (pH 7.4)] were electroporated in the presence of ~25 µg/mL of the appropriate DNA 
construct in a 4-mm cuvette with an exponential pulse of 280 V from a 950 μF capacitor. After 
electroporation, cells were cultured in medium for 24 h. Chemical transfection was carried out by 
mixing 2 μg DNA construct with 8 μL Fugene-HD (Promega) in 100μL Opti-MEM (Life 
Technologies), and this mixture was added to plated cells in 1 mL Opti-MEM in a MatTek 
culture dish. After 1 h incubation, phorbol dibutyrate (0.1 μg/mL) was added to the cells for an 
additional 3 h, then cells were washed into medium for overnight incubation.  
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2.2.3 Flow cytometry sample preparation: 
RBL-2H3 cells were harvested, suspended in medium at a concentration of 5 x 10
6
 
cells/mL, then sensitized with 4 μg/mL Alexa 488-IgE for 1 h at 37°C. They were then washed 
by sedimentation and resuspension in BSS containing BSA (1mg/mL; BSS-BSA). Cells were 
treated with specified drugs for 2 min at 37°C prior to incubation with antigen for 20 min at 
37°C. Samples were then chilled on ice, followed by addition of 5 μg/mL rabbit anti Alexa 488 
IgG and 25 μg/mL human IgG (to block non-specific binding to Fcγ receptors) in BSS-BSA for 
30 min at 4°C. After washing by centrifugation at 4°C, cells were incubated with 10 μg/mL 
Alexa 647-conjugated goat anti rabbit IgG and 25 μg/mL human IgG for 30 min at 4°C. Cells 
were then washed, and fixed with 4% paraformaldehyde and 0.1% glutaraldehyde for 10 min at 
room temperature, followed by washing with PBS containing BSA (10 mg/mL) and storage in 
PBS-BSA (1mg/mL) with 0.01% sodium azide at 4°C. Fluorescent antibody labeling of the cells 
was measured by flow cytometry (BD Biosciences LSR II) using the 488nm argon and 633 nm 
HeNe lasers, and >50,000 cells per sample were evaluated in each experiment. Control samples 
with only Alexa488-IgE or Alexa647-IgE were used to determine the settings to eliminate 
crosstalk between green and far red channels. The percentage of surface-accessible IgE was 
calculated by normalizing far red (Alexa 647 or Cy5) fluorescence for each sample by the far red 
fluorescence value obtained for the cells that were not treated with antigen in each experiment. 
The same samples prepared for flow cytometry were imaged by confocal microscopy, as 
described below.   
2.2.4 Microfabrication of patterned ligands by polymer lift-off.  
Surfaces of silicon wafers were patterned with 1.5 to 4 μm features that were 
functionalized with supported lipid bilayers containing 2,4-dinitrophenyl (DNP) ligands as 
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described previously (33, 34). In brief, small unilamellar vesicles were prepared by sonication. 
The lipid composition was 10 mol% DNP-cap-PE and 90 mol% POPC. For control experiments, 
DNP-cap-PE was not included in the samples. 10 L of the vesicle suspension (1 mM lipids) was 
added to an 8 by 8 mm patterned parylene substrate at room temperature for 10 min. The samples 
were rinsed thoroughly with filtered water, and parylene was mechanically peeled away in 
solution to yield the patterned lipid bilayers. These functionalized surfaces were incubated with 
IgE-sensitized RBL cells as described below. In some experiments, Alexa 488-IgE was used to 
mark IgE-FcεRI that clustered over the liganded features.   
In some experiments the surfaces were patterned with Cy3-conjugated DNP22-BSA. 
These were prepared by functionalizing the patterned parylene with 3-methacryloxypropyl 
tris(trimethylsiloxy)silane (MPTS), followed by washing with ethanol and incubation with 
protein crosslinker, N-[γ-maleimidobutyryloxy] succinimide (GMBS), for 1 h at room 
temperature to generate amine reacting groups. The surfaces are then washed with PBS and 
incubated with 50 μg/mL DNP22-BSA for 1 hour at room temperature, followed by rinsing with 
PBS before peeling off the parylene (35). 
2.2.5 Confocal Fluorescence Microscopy  
Suspended cell samples were imaged in a Zeiss LSM 710 inverted microscope with a 
motorized stage using a 63x Oil Plan-Apochromat lens. Both a 488 nm laser and a 633 nm laser 
were used for excitation of fluorophores.  The images were collected sequentially in green and 
red channels. In separate experiments to study colocalization of dynamin 2-GFP with A647-IgE, 
the cells were plated overnight on a MatTek dish at a concentration of 0.2 x 10
6
 cells/dish, 
transfected the following day, and incubated overnight before sensitization with 2 µg/mL with 
Alexa 647-IgE at room temperature. They were then treated with rabbit anti-IgE serum (1:200 
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dilution) for 15 min at 37°C in presence or absence of cytochalasin D, fixed with 4%  
paraformaldehyde for 20 minutes at room temperature, and then stored in PBS at 4°C. Pearson’s 
correlation coefficients were calculated for each of the samples using a Matlab code
2
 (also 
described elsewhere (36)). The equation used to calculate Pearson’s crosscorrelation coefficient 
is:  
   
∑              
 ∑      
 ∑        
 
Where, xi and yi are the pixel intensity values for green and red channel, respectively, and x, y 
are the average values of xi and yi in the image. A mask is drawn around the cell of interest using 
a Matlab script, and ρ values are calculated for each individual cell. Statistical analyses were 
carried out by calculating the p values using Student’s t-test, and a value of p ≤ 0.05 was 
considered to be statistically significant. 
For experiments involving patterned surfaces, cells (0.5x10
6
/ml) suspended in BSS-BSA 
were added to the functionalized silicon substrate (8 × 8 mm) in the center of a 35-mm Petri dish 
with coverglass bottom (0.16–0.19 mm; MatTek). After the specified incubation time at 37°C, 
cells were fixed with 3.7% formaldehyde in PBS for 10 min followed by quenching with 10 
mg/ml BSA in PBS. For immunofluorescence after fixation, cells were labeled with primary 
antibody at room temperature for 1 h in PBS-BSA (1 mg/mL) containing 0.1% Triton-X. After 
washing, the Alexa 568-labeled secondary antibody was added to samples at room temperature 
for 1 h in continued presence of 0.1% Triton-X. 2mL of PBS was added into the dish before 
inverting the silicon chip for imaging. Cells were imaged in a Bio-Rad-MRC600-confocal head 
coupled with a Zeiss Axiovert 10 inverted microscope. A 522/DF35 filter set was used for 
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 The Matlab code used for image analysis and calculation of Pearson’s coefficient was written by Dr. Christopher 
V Kelly 
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simultaneous or sequential dual-color image acquisition with an oil-immersion 63x/1.4NA 
objective. Cells scored as positive showed fluorescent patterns that matched the patterned 
substrate with intensity in the overlapping patches at least three times greater than the 
background level.  
2.2.6 Knock-down of proteins with siRNA   
siRNA was electroporated into cells using the same conditions as those described above 
for DNA transfection. For optimal knock down, siRNA concentrations and the number of 
electroporations were varied depending on the siRNA used. For clathrin knock-down two 
different siRNAs with sequences, UAAUCCGAUUCGAAGACCAAU and 
AAUGGAUCUCUCUGAAUACGG, were pooled and delivered into the cells with three 
successive electroporations of 1µM siRNA every 24 h. Experiments were performed 24 h after 
the final electroporation. For simultaneous knock-down of cortactin and its homolog, HS1, 
siRNA for cortactin with sequence CCGAGAGAGCUCAGCGGAU and for HS1 with sequence 
UAGAAGAGCCAGUGUACGA (both from ON-TARGETplus, Dharmacon) were pooled and 
delivered into the cells with two consecutive electroporations of 2.5 µM siRNA separated by 24 
h. Experiments with these cells were carried out 24 h after the final electroporation. The 
sequence used for dynamin 2 knock-down was GACAUGAUCCUGCAGUUUA, and optimal 
knock-down was achieved by two consecutive electroporations of 1.5 µM siRNA separated by a 
24 h interval. Experiments were performed 48 h after the final electroporation. An siRNA with 
the sequence UUAACCUUACCGAGGGUCGAA was used as a control in all experiments. 
Protein knock-down was confirmed by immunoblotting with appropriate antibodies.  
 
2.2.7 Immunoblotting 
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Whole-cell lysates were prepared on ice by suspending cells (~3.5x10
5
/mL) in lysis 
buffer [5 mM N-ethylmaleimide, 5 mM EDTA, 0.5% (vol/vol) Triton X-100, 50 mM NaCl, 50 
mM Tris, 1X Halt Protease Inhibitor Cocktail (Pierce, Thermo Fisher) and 1X Halt Phosphatase 
Inhibitor Cocktail (Pierce, Thermo Fisher), pH 7.6]. Lysates were centrifuged at 15,000 x g for 
10 min at 4°C. The supernatant was mixed with 5X Tris-glycine SDS buffer (Pierce, Thermo 
Fisher) and boiled for 5 min. Samples were resolved on a 12% Tris-glycine polyacrylamide gels 
and transferred to an Immobilon-P membrane with a pore size of 0.45 μm (Millipore) by semidry 
transfer. Immunoblots were visualized with Enhanced Chemiluminescence after probing with 
specified antibodies as described previously (37).  
2.2.8 FITC-IgE acidification assay 
For each experiment, 1.8 mL of FITC-IgE-labeled cells (10
6
/mL) were placed in a 
10x10x40 mm acrylic cuvette and stirred continuously in a thermostatic sample chamber at 
37°C. Cells were equilibrated for 5 min in the chamber at 37°C before being stimulated with 500 
ng/mL DNP-BSA or 1:200 dilution of rabbit anti-IgE serum. In some experiments, inhibitors 
were added prior to the stimulation, and cells were equilibrated for 5 min at 37°C. Samples with 
added inhibitors were compared to a control sample measured on the same day. Fluorescence 
measurements were made with an SLM 8000 fluorescence spectrofluorometer operated in ratio 
mode. FITC was excited at 490 nm, and emission was monitored at 520 nm. When the cells are 
stimulated with DNP-BSA, fluorescence quenching of FITC-IgE occurs in two phases, the first 
phase (~ 120 sec) is due to rapid occupancy of DNP in IgE binding sites proximal to FITC (38). 
The second slower phase is due to acidification of endosomes containing crosslinked, 
internalized FITC-IgE (Figure 2.1A; (39)). Only the slower phase of the fluorescence quenching 
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currve, corresponding to endosomal acidification, is observed with stimulation by anti-IgE. The 
percentage quenching due to acidification was calculated with Eqn 1: 
 
F(i) is the steady-state FITC fluorescence prior to the slow phase quenching due to endosomal 
acidification: For stimulation by anti-IgE this corresponds to fluorescence just after its addition; 
for stimulation by DNP-BSA this corresponds to fluorescence after the rapid binding/quenching 
phase (~120 sec after addition). F(f) is the FITC fluorescence 20 minutes after the addition of 
DNP-BSA/anti-IgE. F(b) is the background fluorescence, measured in cells not sensitized with 
FITC-IgE (typically 2-3% of FITC intensity).  
2.2.9 Measurements of FITC-IgE fluorescence sensitivity to extracellular pH 
RBL-2H3 cells were harvested and sensitized with FITC-IgE as described above, then 
washed and stimulated with anti-IgE for 20 min at 37°C in presence or absence of specified 
drugs. After chilling on ice for 5 min, each sample was divided in two parts and pelleted via 
centrifugation at 4°C. One aliquot was resuspended in BSS-MES-BSA (BSS with 20mM 2-(N-
morpholino) ethanesulfonic acid, pH 5.5, replacing HEPES; 1 mg/mL BSA) at 4°C, and the 
other aliquot was resuspended in BSS-BSA at pH 7.4. These samples (10
6
 cells/mL) were 
warmed to 37°C just before measuring in the fluorescence spectrofluorometer operated at 
settings similar to those described for the FITC-IgE acidification assay. The fluorescence was 
measured for > 100 sec for each sample. For samples at pH 5.5, a small amount of NaOH (1M) 
was then added to the cuvette to raise the pH to 7.4, and fluorescence was again measured. After 
these fluorescence measurements, 0.1% Triton-X was added to all samples, and this resulting 
fluorescence was used for normalization. Error bars were calculated from the data obtained for at 
least 3 individual experiments.  
% quenching = [(F(i) – F(f))/(F(i) – F(b))] x 100   
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Results: 
2.3.1 FITC-IgE acidification assay in combination with flow cytometry to evaluate 
internalization 
Crosslinking of FITC-IgE bound to FcεRI on the surface of RBL-2H3 cells by antigen or 
anti-IgE leads to clustering of these receptor complexes that is followed by their internalization 
into endosomes (40, 41), which become acidified by vacuolar pumps as they mature into 
lysosomes (42). As we have characterized previously, the fluorescence of FITC-labeled IgE is 
quenched by DNP occupancy of the IgE binding site (38, 39) and by a decrease in pH due to 
endosomal acidification after FITC-IgE internalization (43). When FITC-IgE on surface of cells 
is crosslinked with DNP22-BSA, a biphasic change in fluorescence occurs. The first phase 
comprises rapid quenching of fluorescence due to the binding of DNP22-BSA to FITC-IgE (38, 
39) and lasts about ~ 120 seconds (Figure 2.1 A).  This is followed by a slower quenching of 
FITC fluorescence, due to the acidification of endosomes. The magnitude of the slower phase of 
FITC fluorescence quenching is calculated using Eqn 1 and is inhibited in presence of 100 nM 
bafilomycin, which is an inhibitor of vacuolar proton pumps (Figure 2.1B). When the cells are 
treated with anti-IgE, only the slower fluorescence quenching due to endosomal acidification is 
observed, and this is inhibited upon pre-treatment with 100 nM bafilomycin (Figure 2.1 A). We 
quantify the extent of acidification by calculating the percentage quenching of FITC-IgE 
fluorescence after 20 minutes of crosslinking by addition of DNP22-BSA or anti-IgE and find 
~40% quenching of FITC-IgE fluorescence due to endosomal acidification (Figure 2.1B). In 
presence of bafilomycin, we see minimal (<5%) decrease in FITC-IgE fluorescence beyond that 
caused by DNP binding. 
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In addition to this endosomal acidification-based assay, we also employed a method to 
monitor the accessibility of IgE-FcRI  to labeling antibodies. Cells sensitized with A488-IgE 
were treated, or not, with DNP22-BSA then incubated with anti-Alexa 488 primary antibody and 
a Cy5 or A647-labeled secondary antibody. The far-red (Cy5 or A647) fluorescence is an 
indicator of the amount of surface-accessible A488-IgE. We can qualitatively assess localization 
of crosslinked IgE by confocal imaging of these samples. The images in Figure (2.2A) show that, 
in absence of antigen, most of the A488-IgE (green channel) is on the plasma membrane and is 
labeled by Cy5/anti-Alexa 488 Ab (red channel). Note that binding of anti-Alexa 488 rabbit IgG 
substantially quenches the Alexa 488 fluorescence. In the cells incubated with DNP22-BSA at 
37°C for 20 minutes, majority of A488-IgE clusters appear to be inside the cells, and therefore 
not labeled by Cy5/anti-Alexa 488. The amount of surface accessible A488-IgE is quantitatively 
measured on a flow cytometer, where monitoring the far red fluorescence (Figure 2.2B) shows 
that the amount of surface accessible IgE in cells incubated with DNP22-BSA at 37°C is 
significantly less (~65%) than samples in which cells are not treated with DNP22-BSA or are 
treated with DNP22-BSA at 4°C, where, in both cases, internalization is minimalWe also observe 
that 100 nM bafilomycin pretreatment does not inhibit the loss of surface accessiblity of IgE 
receptor upon antigen treatment, as measured by flow cytometry. This result verifies the validity 
of this assay for quantitative assessment of the extent of surface accessibility of IgE in a manner 
that does not depend on the acidification of IgE containing endosomes.  
IgE-FcRI crosslinked with anti-IgE or DNP22-BSA can be in different states, as depicted 
in Figure 2.3A. Crosslinked IgE-FcRI complexes can be on the surface and labeled by the anti-
Alexa-488 antibody, and this is detectable by flow cytometry, as illustrated for state I in Figure 
2.3A.  However, if crosslinked complexes are in membrane invaginations that are not cleaved  
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Figure 2.1 FITC-IgE acidification assay determines the extent of acidification of IgE 
containing endosomes: A) RBL-2H3 cells, sensitized with FITC-IgE and suspended at 10
6
 
cells/mL at 37°C, were treated with 1:200 dilution of rabbit anti-IgE serum or 500 ng/mL 
DNP22-BSA (antigen). As shown in this representative experiment, FITC fluorescence of the 
samples was monitored on a fluorimeter for 20 minutes after the addition of anti-IgE serum or 
antigen. B) The extent of acidification was quantified with Eqn 1 by calculating the 
percentage of FITC fluorescence quenching in 20 minutes starting from 120 seconds after the 
addition of anti-IgE or DNP22-BSA. Error bars represent the SEM for 3 individual 
fluorescence quenching experients.  
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Figure 2.2 Confocal imaging and flow cytometry for quantification of surface accessible 
IgE: A) RBL-2H3 cells, suspended in BSS-BSA at a concentration of 5 x 10
6
 cells/mL, were 
sensitized with A488-IgE then incubated with or without antigen and labeled with anti–Alexa 
488 primary antibody followed by washing and labeling with Cy5 labeled secondary antibody 
at 4°C (as described in Materials and Methods). The cells were then fixed, and two-color 
fluorescence images of the equatorial slice were taken by a confocal microscope (Scale bar 
10µm). B) The amount of surface-accessible of A488-IgE is quantified using flow cytometry 
by measuring the far red fluorescence corresponding to A647 or Cy5 secondary antibodies 
bound to anti-Alexa 488 primary antibodies. Values are normalized such that 100% A488-IgE 
on surface is characterized from the ‘no antigen’ sample. Error bars represent SEM over 3 
different experiments. 
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Figure 2.3: States of IgE bound to FcεRI before and after crosslinking: A) Cartoon represents 
the possible states of IgE: (I) IgE, present on the surface of the plasma membrane, can be labeled 
by fluorescent primary secondary antibodies without cell permeabilization. (II) IgE, present in 
membrane invaginations that are not cleaved from the surface of the plasma membrane, is not 
accessible to labeling by fluorescent primary and secondary antibodies. However, IgE in this 
location continues to experience extracellular pH levels. (III)  IgE, present in  endosomes that are 
cleaved from the plasma membrane, but not acidified. (IV)  IgE, present in endosomes that are 
acidified, which results in quenching of FITC-IgE fluorescence.  In these studies, we refer to IgE 
as being internalized after endosomes pinch off from the plasma membrane (states III or IV). B) 
Likely state(s) of crosslinked IgE under different experimental conditons, as determined  from 
three independent and quantitative internalization assays.  
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from the plasma membrane (State II), they may not be surface labeled by the anti-Alexa 488 
antibody yet remain sensitive to the pH of the extracellular medium. Alternatively, internalized 
IgE may be in endosomes that are cleaved from plasma membrane but not acidified, as is the 
case with bafilomycin pretreatment (State III), in which case the fluorescence FITC-IgE will not 
be quenched. The FITC-IgE acidification assay detects internalization only after the IgE 
containing endosomes are pinched off and acidified (State IV). The possible states of crosslinked 
IgE receptors are depicted in the Figure 2.3A and summarized in in Figure 2.3B, where the 
possible conclusions from each individual assay used to assess state of IgE-FcεRI complexes 
after crosslinking are indicated. Out of the four possible states, the one state that is common in 
three different assays has been listed as the most probable state of FcεRI post aggregation in 
those conditions. The result listed under the column pH sensitivity indicates that in those 
conditions, crosslinked FITC-IgE is sensitive to changes in extracellular pH.  
2.3.2 Internalization of crosslinked IgE-FcεRI is sensitive to the size of the clusters and to 
mild cholesterol reduction 
Previously, we developed and characterized structurally rigid Y-shaped DNA ligands that 
are conjugated with dinitrophenyl (DNP) on each 5’ end (Figure 2.4A). We used these ligands to 
probe the structural requirements of FcεRI signaling, and showed that some of these ligands 
stimulate robust degranulation responses (5). The level of stimulation varied with the spacing 
between DNP moieties in the trivalent ligand. In comparison, various studies using bivalent 
ligands have shown that they stimulate only very limited degranulation responses (28). These 
studies indicate that IgE-FcεRI signaling is regulated by the geometry, valency, and spacer 
length of the crosslinking ligands. We performed experiments using these structurally rigid 
DNP-conjugated Y-DNA ligands to probe the structural constraints of IgE-FcεRI  complexes in 
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the process of IgE-FcεRI  internalization. We found that 50 nM Y-16 DNP3 caused maximal 
degranulation in presence of 2 µM cytochalasin D (~50%; data not shown), and somewhat 
weaker responses (~25%) in absence of cytochalasin D, consistent with previous observations 
(5). Treatment of FITC-IgE sensitized RBL-2H3 cells with 50 nM Y-16 DNP3 caused minimal 
quenching of FITC-IgE fluorescence (<5%) subsequent to initial quenching due to binding 
(Figure 2.4 B,C). 50 nM Y-16 DNP3 is sufficient to saturate IgE binding sites on the surface of 
mast cells, as additional Y-16 DNP3 doesn’t cause further quenching of FITC-IgE fluorescence 
(data not shown). Flow cytometry measurements showed that, in contrast to cells treated with 
multivalent antigen, 50 nM Y-16 DNP3 causes only a slight reduction of A488-IgE at the cell 
surface 20 minutes after incubation with this ligand at 37°C (Figure 2.4D). These results indicate 
that IgE-FcεRI clusters formed by Y-16 DNP3 are sufficient to stimulate degranulation but do 
not lead to internalization of IgE-FcεRI complexes. 
Ordered membrane domains enriched in cholesterol and sphingolipids, have been 
strongly implicated in IgE receptor signaling (44). A previous study reported a decrease in the 
extent of IgE receptor endocytosis, assessed via flow cytometry, upon cholesterol reduction by 
10 mM MβCD pretreatment for 30 min at 37°C (27). We found that, following cholesterol 
depletion with 4 mM MβCD for 20 min at 37°C, no quenching of FITC-IgE fluorescence due to 
acidification of the IgE containing endosomes could be detected (Figure 2.5A). In contrast, our 
flow cytometry data shows reduction in surface accessibility of A488-IgE after antigen treatment 
both with and without MβCD pretreatment (Figure 2.5D).  These results do not distinguish 
whether, after cholesterol reduction, crosslinked IgE-FcεRI are retained in membrane 
invaginations that are not cleaved from the plasma membrane (State II, Figure 2.3A), or are in 
endosomes that are cleaved from plasma membrane but not acidified (State III, Figure 2.3A).   
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Figure 2.4: The trivalent ligand – Y-16DNP3 does not lead to internalization of FcεRI 
receptor: A) A schematic of trivalent Y-DNP3 ligands.  The chains represent DNA strands where 
the 5’ end of each DNA is conjugated to DNP via a flexible linker (adopted from (5)). B) RBL-
2H3 cells sensitized with FITC-IgE are treated with Y-16DNP3 or antigen. FITC fluorescence is 
measured on a fluorimeter, and the data plotted are from one representative experiment. C) 
Quantification of FITC-IgE acidification, carried out as described for Figure 2.1. D) The amount 
of surface-accessible A488-IgE before and after crosslinking with antigen or Y-16DNP3 is 
analyzed and quantified using flow cytometry as described for Figure 2.2, the error bars for both 
the assays represent SEM over 3 individual experiments. 
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Figure 2.5: Mild cholesterol reduction with MβCD inhibits FITC-IgE quenching, but not 
surface inaccessibility of IgE: A) RBL-2H3 cells are sensitized with FITC-IgE. Mild cholesterol 
reduction is performed by pretreatment of RBL-2H3 cells with 4 mM MβCD for 20 minutes at 
37°C. Cells are subsequently treated with 1:200 dilution of rabbit anti-IgE serum, and FITC 
fluorescence is measured on a fluorimeter. The plot shows fluorescence levels from one 
representative experiment. B) Quantification of FITC-IgE acidification is performed, as described 
in Figure 2.1. C) The amount of surface-accessible A488-IgE before and after crosslinking with 
antigen in the presence or absence of MβCD treatment is quantified using flow cytometry as 
described for Figure 2.2. The error bars in B and C represent SEM over 3 individual experiments.  
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We designed an experimental scheme to distinguish the above two possibilities. For this 
purpose, we utilized the dependence of FITC fluorescence on pH to determine whether FITC-IgE 
retains sensitivity to pH changes in the extracellular environment, which we could vary (45, 46). 
RBL-2H3 cells sensitized with FITC-IgE were incubated with anti-IgE, with or without MβCD 
pretreatment, at pH 7.4 for 20 minutes at 37°C. The cells were chilled on ice, washed, and 
resuspended in MES-buffered BSS- BSA, pH 5.5. Fluorescence of the cells was measured by 
fluorimetry, before and after the pH was increased to 7.4, via addition of NaOH, followed by 
addition of 0.1% Triton-X. Raw data, along with the time points of various additions are shown 
in Figure 2.6A. The average fluorescence readings for multiple experiments, normalized to 
Triton-X100 values, are plotted in Figure 2.6B. The green bars show the fluorescence values of 
samples that were maintained at pH 7.4 throughout the experiment, and The lower fluorescence 
value for samples treated with anti-IgE is due to endosomal acidification, which is inhibited due 
to MβCD pretreatment. The blue bars represent the FITC fluorescence values at pH 5.5, and the 
red bars represent the FITC fluorescence values after the pH is increased to 7.4. These results 
indicate that crosslinked FITC-IgE in samples following mild cholesterol depletion are sensitive 
to changes in extracellular pH, and thus these IgE-containing endosomes are not cleaved from 
the plasma membrane. Thus, the results are consistent with the crosslinked IgE concentrating in 
membrane invaginations that are not pinched off from the plasma membrane following mild 
cholesterol reduction via MβCD pretreatment.  
2.3.3 Syk is necessary for internalization of IgE receptors 
Syk is a tyrosine kinase activated early in the signaling cascade of FcεRI following clustering 
and tyrosine phosphorylation of FcεRI (47). There have been contradicting reports for the role of 
Syk kinase in internalization of clustered IgE-FcεRI. For example, it was found that this  
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Figure 2.6 Upon mild cholesterol reduction, the majority of crosslinked IgE is sensitive to 
changes in extracellular environment: RBL-2H3 cells are sensitized with FITC-IgE and 
stimulated (or not) with anti-IgE for 20 minutes at 37°C prior to being chilled and resuspended in 
fresh buffer with indicated pH. Designated samples were treated with 4 mM MβCD for 20 minutes 
at 37°C prior to antigen addition. A) (left side) FITC fluorescence intensity of cell samples 
resuspended in BSS, pH 7.4, before and after addition of tritonX-100; (right side), cell samples 
resuspended in BSS at pH 5.5, which is then adjusted to pH 7.4 by addition of NaOH, before 
addition of triton-X. All fluorescence values are normalized to the values obtained after triton-X 
addition. B) Quantification of data for each sample is done by first normalizing all fluorescence 
values to that obtained after triton-X addition and then plotting the normalized fluorescence values 
for the samples subjected to different pH conditions, as represented in (A). Error bars represent the 
SEM over 3 different experiments. 
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Figure 2.7 Syk -/- cells do not show internalization of IgE: A) RBL-2H3 cells or Syk -/- cells 
are sensitized with FITC-IgE before stimulation with 500 ng/mL antigen. FITC fluorescence is 
measured on a fluorimeter. Normalized FITC fluorescence is plotted for one representative 
experiment,120 seconds after the addition of antigen. B) Quantification of FITC-IgE acidification 
is performed as described in Figure 2.1. C) Flow cytometry analysis for quantification of surface 
accessible A488-IgE in RBL-2H3 and Syk -/- cells is performed as described in Figure 2.2. The 
error bars in B and C represent SEM over 3 individual experiments.  
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endocytosis of crosslinked IgE-FcεRI is reduced in Syk deficient cells as measured by flow 
cytometry (48), while others using similar cell lines report no effect on extent of IgE-FcεRI 
internalization and an enhanced rate of internalized receptor transport to lysosomes as measured 
via flow cytometry and confocal microscopy in fixed cells (13). We find that endocytosis of IgE 
receptors in Syk-/- cells (TB1A2 cell line, (49)) is substantially inhibited as detected by FITC-
IgE acidification assay (Figure 2.7B). Consistent with this, our flow cytometry measurements 
show that most of the Alexa 488-IgE remains surface accessible upon binding by antigen at 37°C 
(Figure 2.7C). The presence of Syk appears to be essential for the signaling pathway leading to 
the internalization of activated FcεRI receptor at the cell surface.  
2.3.4 F-actin cycling is important for pinching off of IgE-containing endosomes from the 
plasma membrane. 
Inhibition of crosslink-dependent IgE receptor endocytosis by the inhibitor of actin 
polymerization, cytochalasin D, was first reported in 1989 (40). Using our acidification assay, 
we find that 2 M cytochalasin D prevents crosslink-dependent acidification of IgE receptor 
complexes, as does another inhibitor of actin polymerization, latrunculin  A at 1 μM (Figure 
2.8A and B). This inhibition of acidification is dose dependent, such that cells treated with 0.25 
μM cytochalasin D exhibited negligible inhibition of FITC-IgE acidification (data not 
shown).We also observed inhibition of internalization-dependent acidification by jasplakinolide, 
which stabilizes the actin cytoskeleton. These results indicate that dynamic cycling of F-actin is 
important for internalization-dependent acidification.  
In contrast to effective inhibition of acidification, these agents did not prevent loss of surface 
accessibility of A488-IgE-FcRI after crosslinking with antigen (Figure 2.9B). When the  
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Figure 2.8 Inhibition of F-actin cycling abolishes FITC-IgE quenching upon crosslinking: 
(A) RBL-2H3 cells sensitized with FITC-IgE and pretreated with 2 μM cytochalasin D or 1 μM 
latrunculin A for 2 minutes at 37°C, or with 3 μM jasplakinolide for 30 minutes at 37°C, prior to 
treatment with anti-IgE. FITC fluorescence was measured on a fluorimeter, the plot shows a 
representative experiment. (B) Quantification of FITC-IgE acidification data is performed as 
described in Figure 2.1. The error bar represents SEM over 3 individual experiments.  
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Figure 2.9 IgE becomes less surface-inaccessible upon treatment with antigen in presence or 
absence of F-actin cycling inhibitors: A) RBL-2H3, suspended in BSS (5 x 10
6
/mL) are 
sensitized with A488-IgE. They are subsequently treated with 2 µM cytochalasin D (or not), 
followed by treatment with antigen for 20 minutes at 37°C (or not). The cells are subsequently 
chilled, labeled with anti-Alexa 488 primary, Cy5 or A647 tagged secondary antibody, and 
subsequently imaged on a confocal microscope. The top panel shows unstimulated cells, and the 
bottom panel shows cells treated with cytochalasin D followed by antigen (Scale bar 10μm). B) 
Quantification of surface accessible A488-IgE is performed as described in Figure 2.2. The error 
bars represent SEM from 3 individual experiments.  
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cells were visualized via confocal microscopy, we observed formation of IgE-containing 
endosomes due to antigen crosslinking that were not labeled by the primary (anti-Alexa488) and 
secondary antibodies (Figure 2.9A). Inhibition of acidification of FITC-IgE after crosslinking in 
presence of cytochalasin D is reversible.  
To further investigate if the endosomes are pinched off from the plasma membrane after 
antigen treatment in presence of cytochalasin D, we utilized the dependence of fluorescence of 
crosslinked FITC-IgE on extracellular pH as described in Figure 2.6. Raw data for different 
samples, along with the time points of additions of reagents are shown in Figure 2.10A. The 
average fluorescence readings for each sample (normalized to values following 0.1% Triton-
X100 treatment) are summarized in Figure 2.10B. These results indicate that crosslinked FITC-
IgE in presence of cytochalasin D is sensitive to changes in extracellular pH. These results 
suggest that crosslinked IgE in the presence of cytochalasin D is not internalized, but becomes 
inaccessible to the surface labeling anti-Alexa 488 antibodies, as represented by State II in 
Figure 2.3A. In our experiments, we find that washing out cytochalasin D restores quenching of 
FITC-IgE fluorescence due to acidification (Figure 2.11A). 
 When we add 2 μM cytochalasin D to the cells containing acidified FITC-IgE after 
crosslinking, we find an increase in FITC fluorescence. This increase in FITC-IgE fluorescence 
may be explained by the increased exocytosis in suspended cells upon addition of inhibitors of F-
actin polymerization. Consistent with this explanation, when a similar experiment is performed 
in absence of extracellular Ca
2+
, this increase in fluorescence is inhibited. (Figure 2.11B).    
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Figure 2.10 F-actin inhibition prevents the cleaving of endosomes containing crosslinked IgE 
from the plasma membrane: Experiment and analysis were performed similarly from Figure 2.6.  
A) FITC-IgE sensitized RBL-2H3 cells were treated with the 2 μM cytochalasin D or not, prior to 
stimulation with 1:200 dilultion of rabbit anti-IgE serum. B) The bar graph represents the 
normalized fluorescence values of FITC-IgE, averaged over there different experiments. Error bar 
represents SEM over 3 individual experiments.  
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Figure 2.11 Inhibition of FITC-IgE acidification by inhibition of F-actin cycling is reversible: 
A) RBL-2H3 cells sensitized with FITC-IgE and treated with 1:200 dilution of rabbit anti-IgE 
serum (or not) in the presence or absence of 2 µM cytochalasin D at 37°C. The cells are 
subsequently chilled on ice and centrifuged, and resuspended in BSS-BSA with or without 
cytochalasin D, and are allowed to incubate for 20 minutes at 37°C. Fluorescence is then measured 
on a fluorimeter and the values are normalized for each sample, based on the values obtained after 
adding 0.1% Triton-X. The error bar represents SEM over 3 invididual experiments. B) RBL-2H3 
cells, sensitized with FITC-IgE are resuspended in BSS with or without calcium and treated with 
rabbit anti-IgE serum and fluorescence is measured. 2 μM Cytochalasin D is added to the cells 15 
minutes after the addition of anti-IgE. 2 mM Calcium Chlroide was added to the cells suspended 
in BSS without extracellular calcium, 5 minutes after addition of cytochalasin D. The plot shows 
values from one representative experiment. 
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 2.3.5 IgE receptor internalization exhibits partial dependence on dynamin 2: 
IgE internalization after crosslinking has been found to be clathrin-independent in one 
study (12), whereas some electron microscopy studies found crosslinked IgE receptor 
colocalized with clathrin (17, 18). Previous reports in the literature describe the involvement of 
actin binding proteins, dynamin and cortactin, in clathrin-dependent and clathrin-independent 
endocytosis (50). To further probe the role of these proteins in the internalization of crosslinked 
IgE receptors, we employed siRNA to selectively knock down dynamin 2, clathrin heavy chain, 
cortactin, and the cortactin homolog HS1 (Hematopoietic lineage cell specific protein 1, also 
known as hematopoietic cell-specific Lyn substrate 1). As shown in Figure 2.12A, we detect 
>95% knock-down of dynamin 2, clathrin and HS1, and ~75% knock-down of cortactin, as 
detected by immunoblotting. Cortactin and HS1 were knocked down simultaneously because of 
the possible functional redundancy between these two closely related homologs (51). Dynamin 2 
expression levels were detected by immunoblotting with an anti-dynamin 1 antibody that cross-
reacts with dynamin 2. Given that no dynamin is detected under these conditions, it is likely that 
dynamin 2 is the principal isoform of dynamin expressed in these cells. 
Knock-down of cortactin and HS1 or clathrin heavy chain did not cause a significant 
change in the internalization of antigen-crosslinked IgE receptor, as monitored by FITC-IgE 
fluorescence quenching due to endosomal acidification (Figure 2.12B). However, knock down of 
dynamin 2 caused ~ 25% inhibition of FITC-IgE quenching due to endosomal acidification in 
comparison with cells treated with control siRNA (Figure 2.12B). This result is consistent with a 
previously detected role of dynamin 2 in the internalization of FcεRI receptor (12). It is notable 
that > 95% knock down of dynamin 2 led to only a 25% difference in response of IgE 
internalization. There is a possibility that residual endogenous dynamin 2 after the dynamin 2 
77 
 
siRNA treatment can cause vesicle scission from the plasma membrane. An alternative 
explanation is that a substantial portion of IgE receptor endocytosis is dynamin 2-independent. 
Dynamin independent internalization pathways have been reported in literature (reviewed in 
(15)). As crosslink-dependent IgE receptor endocytosis depends on cholesterol, it is also possible 
that the mechanism of this process is different from the high membrane curvature required for 
dynamin-dependent pinching of endocytic vesicles. 
2.3.6 Studies with patterned ligand surfaces reveal the role of dynamin in the organization 
of actin cytoskeleton at sites of IgE receptor clustering. 
We previously described the use of micropatterned ligand arrays in combination with 
fluorescence microscopy to visualize the spatially defined recruitment of signaling components 
in the IgE receptor signaling cascade (Figure 2.13A) (37, 52). Because IgE-specific ligands are 
confined to the patterned surface, IgE receptor complexes are not internalized, and accumulation 
of other components remain stable for relatively long times (> 30 minutes). Utilizing micro-
patterned, immobilized DNP-liganded bilayers, and incubating with IgE-sensitized RBL-2H3 
cells, we found that dynamin 2 (detected by immunofluorescence) accumulates at the ligand 
patches (Figure 2.13B). Accumulation of dynamin 2 is maximal by ~30 min after incubation of 
cells (observed in >70% cells), and remains stable for at least 45 minutes. This time scale is 
similar to observed accumulation of actin, as we previously reported (53). Dynamin 2-EGFP and 
the dominant negative mutant Dynamin 2 K44A-EGFP also show recruitment to the clustered 
receptors (data not shown). Moreover, this selective recruitment of dynamin is not prevented by 
addition of 2 µM cytochalasin D, and is detected in >65% of imaged cells under these conditions 
(Figure 2.13B). This indicates that recruitment of dynamin 2 to activated IgE receptors does not 
depend on actin polymerization. Data adapted from (1). 
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Figure 2.12 IgE internalization can be independent on clathrin and cortactin, but dependent 
on Dynamin-2: A) RBL-2H3 cells transfected with control or dynamin 2 or clathrin or cortactin si 
RNA and western blotting samples were prepared with the appropriate antibodies from the cell 
lysates. B) Cells transiently transfected with control or dynamin 2, clathrin or cortactin siRNA 
prior to harvesting and sensitization with FITC-IgE. The cells were then stimulated with antigen, 
and fluorescence of FITC-IgE was recorded with a fluorimeter. The data plotted in the graphs 
shows the FITC-IgE fluorescence values 120 sec after the addition of antigen (Figure adopted 
from PhD Thesis, Alexis Torres). C) Quantification of the quenching of FITC-IgE fluorescence 
due to acidification was performed as described in Figure 2.1. The error bars represent SEM over 
3 individual experiments. * represents p<0.05. 
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Figure 2.13 Dynamin 2 plays a role in recruitment of the actin cytoskeleton to micro-
patterned ligand surfaces: A) A schematic showing the use of micro-patterned ligand surfaces to 
study the spatial recruitment of IgE signaling partners. B) RBL-2H3 cells sensitized with A488-
IgE (green channel) are pretreated with 2 μM cytochalasin D or not, and plated onto 
micropatterned DNP containing lipid bilayers for 40 minutes at 37°C prior to fixation. Cells are 
subsequently immunolabeled with an anti-dynamin 2 and A568 tagged secondary antibody (red 
channel). Cells are scored as positive when the fluorescence on top of the antigen clusters is at 
least 3 times higher than the fluorescence on the cells away from the patterns. More than 70% of 
the cells were scored positive for the recruitment of dynamin 2 to the activated receptor complex 
(n > 90 cells for each sample). C) RBL-2H3 were transiently transfected with dynamin 2 siRNA or 
control siRNA, sensitized with A488-IgE, and plated onto micropatterned DNP containing lipid 
bilayers for 40 minutes at 37°C prior to fixation. Cells are subsequently immunolabeled with A568 
phalloidin. D) A bar graph demonstrating that the percentage of cells scored positive for F-actin 
recruitment to ligand. Cells are scored as positive when the fluorescence on top of the antigen 
clusters is at least 3 times higher than the fluorescence on the cells away from the patterns.  
(Modified from PhD thesis - Alexis Torres (1)). 
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Dynamin 2 is has been characterized for its role in the later stages of receptor mediated cell 
signaling, mainly for the scission of endosomal vesicles forming on the plasma membrane of the 
cells (54, 55). However, our data with micropatterned surfaces suggests that dynamin 2 is 
recruited to clustered FcεRI receptors, even under conditions where internalization is inhibited. 
There is evidence for the interactions between dynamin 2 and actin regulating proteins, such as 
profilin (56) and cortactin (57). To test the involvement of dynamin 2 in the recruitment of actin 
cytoskeleton to the clustered IgE-FcεRI, we compared F-actin clustering in control and dynamin 
2 knock-down (KD) cells. In dynamin 2 KD cells, accumulation of F-actin to aggregated 
receptors over patterned ligands was highly reduced (Figure 2.13C and D). This dependency of 
actin cytoskeleton clustering on dynamin 2 might involve direct or indirect interactions of 
dynamin 2 with actin binding proteins such as Abp1, cortactin, profilin.  
To probe the role of actin cytoskeleton in the activity of dynamin 2 with IgE-FcεRI that 
had been clustered with soluble anti-IgE, we measured colocalization of IgE clusters with 
dynamin 2-GFP in presence and absence of cytochalasin D. RBL-2H3 cells transiently 
transfected with dynamin 2-GFP and sensitized with A647-IgE, were treated with anti-IgE for 15 
min in presence and absence of cytochalasin D at 37°C. Representative confocal images show 
increase in colocalization of dynamin2-GFP with crosslinked A647-IgE in the presence of 
cytochalasin D (Figure 2.14A). This colocalization was quantified by calculating the Pearson’s 
cross correlation coefficient. We find a 2-fold increase in the value of Pearson’s coefficient for 
the cells treated with anti-IgE in presence of cytochalasin-D compared to its absence (Figure 
2.14B). These results, taken together provide evidence that dynamin 2 is recruited to clustered 
IgE-FcεRI complexes independent of its association with F-actin. As shown above, in the 
absence of actin polymerization, the budding IgE-containing endosomes are not cleaved, and in 
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the results shown in Figure 2.14, cytochalasin D causes a more stable association of dynamin 2 
with clustered IgE-FcεRI at the plasma membrane. In combination, these results indicate that 
dynamin 2 plays a role in internalization of IgE, either directly, or by regulating the F-actin 
cytoskeleton. 
2.3.7 PI(4,5)P2 is involved in FcεRI internalization: 
Previously, we characterized the effects of interfering with PI(4,5)P2 synthesis by 
treatments with phenylarsine-oxide (PAO), a known inhibitor for PI4K IIIα (58), and quercetin, 
an inhibitor of PI4K (59) and PI5K, as well as other kinases (2). With these reagents we 
observed complete inhibition of acidification of FITC-IgE upon treatment with anti-IgE, as well 
as lack of labeling of surface accessible IgE as labeled by an anti-Alexa 488 antibody (2). 
Confocal imaging showed that cells treated with antigen in the presence of 20 μM quercetin or 5 
μM PAO have crosslinked IgE-containing endosomes, proximal to the plasma membrane but not 
labeled by a surface labeling antibody (2). These results suggested the formation of crosslinked 
IgE-containing membrane invaginations that have not been cleaved from plasma membrane.  
We used our method to assess the accessibility of crosslinked receptors to the 
extracellular medium in presence and absence of these PI kinase inhibitors. As shown in Figure 
2.15, FITC-IgE on samples treated with anti-IgE in the presence of 20 μM quercetin or 5 μM 
PAO is sensitive to the changes in extracellular pH, and by this criterion it remains connected to 
the plasma membrane (state II, Figure 2.3).  
 
2.3.8 Interfering with PI(4,5)P2 synthesis affects recruitment of actin to micropatterned 
ligand surfaces. 
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Figure 2.14 Dynamin shows increased colocalization with crosslinked IgE clusters in the 
presence of cytochalasin-D: A) RBL-2H3, plated on a Mat-tek well are transiently transfected 
with dynamin 2 GFP. The cells are then sensitized with 2 μg/mL A647-IgE for 1 hour and excess 
A647-IgE is washed off with BSS-BSA. The cells are then treated with 2 µM cytochalasin D 
(bottom panel) or not (top panel). They are then stimulated with 1:200 dilution with anti-IgE 
serum for 15 min at 37°C prior to fixation. The confocal images show dynamin 2-GFP (green 
channel) and  A647-IgE (red channel) and the overlay of cells treated with anti-IgE in absence (top 
panel) or presence of 2 µM cytochalasin D (bottom panel). B) The data is quantified by calculation 
of Pearson’s coefficients for n > 30 cells for each condition over 2 individual experiments. The 
error bars represent SEM for all Pearson’s coefficient for all the cells analyzed in each condition. 
Scale Bar: 10μm  
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Figure 2.15: Inhibition of PI(4,5)P2 synthesis prevents the pinching of crosslinked IgE 
containing endosomes from the plasma membrane. A) RBL-2H3 cells sensitized with FITC-
IgE are pretreated with 5 μM PAO or 20 μM quercetin or control and stimulated with 1:200 
dilution of anti-IgE serum at 37°C. The fluorescence of FITC-IgE in the samples is measured on a 
fluorimeter.The plots show data from one representative experiment. B) Flow cytometery samples 
are prepared and analyzed as described in Figure 2.2. (Data from A and B is adopted (2)) C) 
Experiments to test the pH sensitivity of crosslinked FITC-IgE were performed as described 
previously in Figure 2.6. FITC-IgE sensitized RBL-2H3 cells were treated with the 5 μM PAO or 
20 μM quercetin prior to stimulation with 1: 200 dilultion of anti-IgE serum. The bar graph 
represents the normalized fluorescence values of FITC-IgE.. Error bar represents SEM over 3 
individual experiments.  
 
  
87 
 
 
  
88 
 
Figure 2.16: PI(4,5)P2 synthesis is important for recruitment of F-actin to micro-patterned 
antigen surfaces: A) RBL-2H3 cells are harvested, sensitized with IgE and resuspended in BSS-
BSA (1 mg/mL) at a concentration of 10
6
/mL, and treated with 2 µM PAO or 20 µM quercetin or 
control (no drug added) for 5 minutes.  These cells are plated for 40 minutes at 37°C on micro-
patterned, covalently attached DNP22-BSA(antigen) conjugated to Cy3 and then fixed. The cells 
are then stained for F-actin using A488-phalloidin, and are imaged on a confocal microscope. The 
top panel in the figure shows untreated cells, the middle panel shows the cells treated with 2 µM 
PAO, and bottom panel shows cells treated with 20 µM quercetin. B) A bar graph demonstrating 
the percentage of cells scored positive for F-actin recruitment to ligand. Cells are scored as 
positive when the fluorescence on top of the antigen clusters is at least 3 times higher than the 
fluorescence on the cells away from the patterns. Data represents an average of >150 cells scored 
in 3 individual experiments. 
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PI(4,5)P2 is known to interact with actin-associated proteins (60), and thus it might 
participate in the interactions of actin associated-proteins with clustered IgE-FcεRI complexes. 
Previous studies in our laboratory showed that paxillin, vinculin, and talin are some of the actin-
associated proteins that are recruited with IgE receptors to the micro-patterned ligands along 
with F-actin (36). To investigate the importance of PI(4,5)P2 in mediating these interactions, we 
plated the RBL cells sensitized with IgE on the micropatterned ligand surfaces. In absence of any 
pharmacological treatment, we find that >90% cells are positive for recruitment of actin 
cytoskeleton, as detected by A488-phalloidin. In comparison, we find that incubation with 2 μM 
PAO or 20 μM quercetin, substantially reduces the number of cells showing F-actin 
accumulation (Figure 2.16).  These results suggest that PI(4,5)P2 participates in interactions of 
activated IgE receptors with the actin cytoskeleton, either directly or indirectly, probably by 
recruitment of actin-associated proteins. 
 
2.4 Discussion 
When IgE bound to FcεRI receptors on the surface of mast cells is crosslinked with a 
multivalent antigen, a signaling cascade is initiated leading to release of inflammatory mediators 
(47). Subsequently, a large fraction of FcεRI/IgE/antigen complexes are internalized in 
endosomes that mature into lysosomes as the complexes are degraded (13). As described in 
Figure 2.3A, four states for the crosslinked IgE-FcεRI complexes are possible: 1) Complexes that 
remain on the surface of the cells and can be labeled by appropriate primary and secondary 
antibodies without permeabilization (State I, Figure 2.3). 2) Complexes that reside in membrane 
invaginations but are not pinched from the plasma membrane and are still susceptible to the 
changes in the extracellular environment (State II, Figure 2.3). 3) Complexes that are in 
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endosomes, cleaved from plasma membrane, but are not yet acidified (State III, Figure 2.3). 4) 
Complexes are in acidified endosomes that mature into lysosomes (State IV, Figure 2.3). 
Commonly, internalization has been studied by radioligand binding and flow cytometry (61). In 
our experiments with flow cytometry, we label FcεRI/IgE on the surface, but not when the 
complexes are either in the membrane invaginations or endocytosed. Membrane invaginations 
that are not cleaved from the plasma membrane have been observed previously via electron 
microscopy during clathrin mediated endocytosis (62). We also utilize the FITC-IgE 
acidification assay to assess the extent of internalization of receptor after acidification of IgE-
FcεRI containing endosomes. The assay that monitors the effect of decreasing extracellular pH 
on FITC-IgE fluorescence gives us information about whether crosslinked FITC-IgE is still 
accessible to the extracellular medium and not internalized. This distinguishes the case when 
FITC-IgE is in endosomes that have cleaved from plasma membrane but not acidified (such as 
with bafilomycin treatment) from the case where they are in endosomes that have not been 
cleaved from plasma membrane. A combination of these methods allows us to specify the state 
of crosslinked IgE-FcεRI complexes. We refer to IgE as internalized when it is in state III or IV, 
as depicted in Figure 2.3A.  
The signaling cascades leading to degranulation and IgE-FcεRI endocytosis depend on 
crosslinking of the receptor complexes. Although the initiation of both of these pathways is the 
same, they diverge after crosslinking, and not much is known about which signaling events are 
necessary for endocytosis. It is known that IgE receptor endocytosis does not depend on 
extracellular Ca
2+
 (Figure 2.10B) (63), which is essential for degranulation in RBL-2H3 cells 
(63). A previous study, in which COS-7 cells were transfected with α,β,γ subunits of FcεRI (64), 
showed that even reconstituted FcεRI receptors missing the cytoplasmic domain on the α,β,γ 
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chains and crosslinked by oligomeric IgE can be endocytosed, although at a slower rate in 
comparison to full length FcεRI receptor in RBL-2H3 (64). This evidence suggests that FcεRI 
endocytosis differs from signaling requirements for degranulation.   
Our laboratory showed previously that FcεRI colocalizes with Lyn kinase, in cholesterol- 
and sphingolipid-rich ordered membrane domains, (related to “DRMs” or “lipid rafts”), upon 
activation by aggregation (23, 24). Cholesterol depletion by MβCD pretreatment prevents the 
localization of aggregated FcεRI into these domains. In addition, it was also demonstrated that 
cholesterol depletion affects receptor phosphorylation and recruitment of different signaling 
partners to the ordered membrane domains (24). A previous study using cholesterol depletion by 
10mM MβCD for 30 min at 37°C showed increased  surface accessibility of crosslinked IgE-
FcεRI complexes via flow cytometry (27). Our results with milder cholesterol depletion using 
4mM MβCD preatreatment for 20 minutes (Figure 2.5, 2.6), suggest that segregation of IgE-
FcεRI in ordered membrane domains is important for the internalization of aggregated IgE 
receptors. We demonstrate that, under these milder conditions, crosslinked IgE-FcεRI goes in 
membrane invaginations that are not labeled by anti-Alexa-488 antibody at the cell surface, but 
they are not cleaved from plasma membrane (Figure 2.6), as depicted in state II, Figure 2.3. 
These data suggest that translocation of receptor to the ordered membrane domains, which is 
sensitive to cholesterol depletion, is important for endocytosis of the crosslinked IgE receptor. 
We also investigated the dependence of internalization on the length of the rigid ligand 
spacer in the IgE receptor clusters (28). We previously developed and characterized rigid 
trivalent DNP-tagged Y-shaped DNA ligands, which stimulated phosphorylation of FcεRI 
receptor and its signaling partners, including Lyn, Syk, and LAT, together with robust 
degranulation responses that depended on the distances between DNP moieties in the Y-DNP3  
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ligands (5). We also found that treatment with Y-16DNP3 led to aggregation of FcεRI bound to 
IgE on the surface of mast cells as detected by confocal fluorescent microscopy (data not 
shown). More recent results quantifying FcεRI receptor aggregation via scanning electron 
microscopy (SEM) showed that stimulation with Y-16DNP3 causes clustering of IgE/FcεRI that 
is less extensive that that when the IgE is crosslinked with DNP22-BSA (65). We find that 
although these ligands cause robust degranulation responses in RBL cells in the presence of 
cytochalasin D, they do not cause any significant internalization of IgE receptor complexes, as 
detected by FITC-IgE acidification and flow cytometry (Figure 2.4). This is in contrast with 
studies with the anti-FcεRI antibodies that form receptor dimers  and cause significant 
internalization as seen via FITC-IgE acidification (29). These results, taken together, suggest that 
the size of aggregated FcεRI clusters is important in initiating the signaling cascade leading to 
internalization of FcεRI receptor. Although structural constraints and limited crosslinking caused 
by Y-16DNP3 stimulation is enough to trigger substantial degranulation responses, more robust 
clustering of IgE-FcεRI complexes appears to be required for internalization of IgE receptor.  
Syk, is an early signaling partner coupled to FcεRI activation by crosslinking (47). In our 
experiments with Syk -/- cells, we find clustering of IgE receptors at optical resolution, but no 
internalization of the IgE receptor as assessed via FITC-IgE acidification as well as by flow 
cytometry (Figure 2.7). This argues that Syk is essential in the internalization pathway, and, in 
absence of Syk, the crosslinked IgE-FcεRI receptor complexes are in state I as depicted in Figure 
2.3.    
Previous studies in assessing the internalization of transferrin receptors in A431 cells by 
flow cytometry and Fcγ receptor internalization in RAW 264.7 macrophages by acid stripping 
found evidence that activation-dependent (Fcγ receptor) and constitutive receptor (transferrin 
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receptor) endocytosis are insensitive to the disruption of actin cytoskeleton (19, 66). In contrast, 
there are several examples that the actin cytoskeleton, either directly or via adapter proteins, 
plays an essential role in endocytosis (67). Previous studies in mast cells, using radiolabeling and 
acid stripping surface accessible IgE to assess internalization found that IgE in presence of 100 
μM cytochalasin B - a drug known to affect formation of microfilaments, doesn’t affect IgE 
internalization after crosslinking with an antigen (63). Other studies using the same method 
found  that IgE internalization is substantially inhibited by 10 μM cytochalasin D (40), 
supporting dependence on the actin cytoskeleton. We find that in the presence of 1 μM 
latrunculin A or 2 μM cytochalasin D, which prevent new polymerization of actin, there is no 
acidification of FITC-IgE upon crosslinking with anti-IgE (Figure 2.7). We see similar results in 
presence of 3 μM jasplakinolide, which stabilizes the actin cytoskeleton. However, flow 
cytometry data shows that crosslinked IgE in presence of inhibitors of F-actin polymerization is 
not labeled with secondary antibodies (Figure 2.8). Upon further investigation, we found that 
crosslinked IgE under these conditions is located in membrane invaginations that are not cleaved 
from the plasma membrane (Figure 2.9) (State II, Figure 2.3). Previous studies have shown a role 
for F-actin in the tubulation (elongation) of membrane invaginations in clathrin dependent 
endocytosis (68). However, our results show that when F-actin polymerization is inhibited, IgE-
FcεRI complexes are trapped in membrane invaginations that are not cleaved from the plasma 
membrane.   
We also find that the inhibition of FITC-IgE acidification by cytochalasin-D is reversible, 
and, upon removal of the drug, we observe fluorescence quenching of crosslinked FITC-IgE 
(Figure 2.8A). Once IgE-FcεRI complexes are internalized after crosslinking, IgE-containing 
endosomes mature into lysosomes and become secretory granules (13). Upon addition of 
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cytochalasin D or latrunculin A to the IgE in acidified in endosomes, we observe an increase in 
FITC-IgE fluorescence (Figure 2.10B). It is likely that the increase in FITC-IgE fluorescence 
upon addition of latrunculin A can be attributed to an increased rate of stimulated exocytosis 
upon addition of actin cytoskeleton destabilizing agents under these conditions (69). To test this 
hypothesis, we did the similar experiment in absence of extracellular Ca
2+
, conditions under 
which exocytosis does not occur. Consistent with our hypothesis, we do not observe the increase 
of the FITC-IgE fluorescence upon cytochalasin D or latrunculin A (Figure 2.10B). 
 
This 
indicates that the FITC-IgE fluorescence quenching observed in absence of inhibitors of F-actin 
polymerization, is a net effect of fluorescence quenching due to the acidification and 
enhancement when the internalized FITC-IgE, fused with secretory granules are exocytosed. 
 
Various receptor internalization pathways are found to be either clathrin dependent (14),  
or clathrin independent (15). Previous studies suggested that FcεRI internalization pathway is 
clathrin mediated, based on colocalization of FcεRI with clathrin coated pits using electron 
microscopy (17, 18). In contrast with this, more recent studies selectively knocked down clathrin 
using siRNA, and found that this has no effect on FcεRI internalization via flow cytometry, but it 
does substantially reduce transferrin internalization (12). Consistent with this, our results using 
siRNA show that IgE receptor internalization is not affected by clathrin knock-down as 
measured by FITC-IgE fluorescence quenching (Figure 2.12). Cortactin and its analog, HS1, are 
also found to be important in both clathrin-mediated (57, 70) and clathrin-independent 
endocytosis (16). Our results show that selective knock down of cortactin and HS1 does not 
affect IgE internalization (Figure 2.12).  
Dynamin 2 is a GTPase found to be essential for both clathrin-mediated and clathrin-
independent endocytosis, primarily for its role in membrane fission to cleave the budding 
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endosomes from the plasma membrane (71). Previous studies have demonstrated that by over 
expressing the dominant negative dynamin 2 K44A mutant, there is a significant decrease in 
FcεRI internalization as measured by flow cytometry (12). We utilize siRNA to selectively 
knock down >95% dynamin 2 expressed in RBL-2H3 cells, and find only 25% decrease in FcεRI 
internalization measured by FITC-IgE acidification (Figure 2.12). This result indicates that there 
is a possibility of some redundancy in the role of dynamin 2 in the FcεRI internalization 
pathway. Dynamin 2, clathrin and cortactin are all expressed in abundance in RBL-2H3 cells, 
and upon using siRNA, we achieve > 90% knock down efficiency of all of these proteins. There 
is a possibility that the residual endogenous proteins after the siRNA treatment are enough to 
play a role in the internalization of FcεRI. In addition, there might be a different dynamin 2-
independent internalization pathways. Therefore, over-expression of dominant negative forms of 
clathrin and cortactin, may shed light on their effects on FcεRI internalization to provide further 
insights into the roles of these proteins in IgE receptor internalization. However, there is a 
possibility that IgE internalization is actin cytoskeleton dependent but dynamin independent 
pathway. 
We previously utilized micropatterned ligand surfaces to study spatially regulated 
signaling in IgE receptors (53, 72). We demonstrated that several actin binding proteins 
commonly associated with focal adhesions, including talin, vinculin, and paxillin, are recruited to 
IgE receptor complexes independently of integrin α-5. We previously hypothesized that these 
proteins might regulate signaling by playing a role as adaptor proteins in linking the IgE receptor 
to the actin cytoskeleton (36). However, in light of the role of the actin cytoskeleton in FcεRI 
internalization, it is possible that recruitment of these actin binding proteins to these 
micropatterned surfaces is a part of the formation of FcεRI internalization machinery.  
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We find that dynamin 2 is recruited to the micropatterned surfaces, and this recruitment is 
independent of actin polymerization (Figure 2.13B). We also find that dynamin 2 knock down 
inhibits the recruitment of F-actin to the activated FcεRI receptor complexes (Figure 2.13 C). 
These results suggest that dynamin 2 plays a direct or indirect role via adaptor proteins in the 
organization of actin cytoskeleton, prior to being involved in vesicle fission, as is commonly 
perceived role of dynamin in endocytosis. This is consistent with some previous observations 
which indicate that dynamin 2 is playing a role in the arrangement of actin cytoskeleton (73, 74). 
The recruitment of dynamin 2 to the receptor clusters might be important for recruitment of other 
proteins involved in the internalization pathway, including bar domain proteins (75, 76). It 
should be noted that over-expression of dominant negative dynamin 2 K44A mutant (which is 
recruited to the activated receptor), did not affect the recruitment of F-actin to micropatterned 
patches (data not shown) in comparison to control samples, indicating that the role of dynamin 2 
in the organization of the actin cytoskeleton is independent of membrane fission activity. 
However, over expression dynamin 2 K44A mutant reduces crosslinked FcεRI receptor 
internalization as measured by flow cytometry (12).We also find that when the actin cytoskeleton 
is disrupted by cytochalasin D pretreatment, dynamin 2 shows increased association with IgE 
receptor complexes, due to crosslinking by soluble anti-IgE for 15 min at 37°C (Figure 2.14). 
This suggests that dynamin 2 plays a role in the organization of actin cytoskeleton, and, in turn, 
the actin cytoskeleton is required for fission of endosomes from the plasma membrane (Figure 
2.11). Although our results demonstrate that the actin cytoskeleton is not essential for the 
formation of FcεRI-containing membrane invaginations in RBL-2H3 cells. 
Phosphoinositides mediate a wide variety of signaling processes in cells (22). They are 
known to play an important role in endocytosis, serving as targeted binding sites for the 
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recruitment and subsequent regulation of endocytic proteins to the plasma membrane including 
dynamin (75). PI(4,5)P2 is also known to regulate the actin cytoskeleton at the sites of receptor 
endocytosis (20). Previous results have shown that clathrin-independent endocytosis is also 
dependent on Arf 6 (77-79). Given that Arf 6 is known to function in the regulation of the 
cortical actin cytoskeleton by PIP5K (80), PI(4,5)P2 might be an important regulator in the FcεRI 
endocytosis, which is known to be clathrin-independent (Figure 2.12) (12). PI(4,5)P2 constitutes 
~ 1% of the total lipid content of the plasma membrane, and it needs constant replenishment as it 
is hydrolyzed by PLCγ, and converted to phosphatitylinositol 3,4,5-triphosphate (PIP3) by 
phosphatidylinositol 3- kinases (PI3K). The source of PI(4,5)P2 in cells is by phosphorylation of 
PI(4)P via PI(4)P-5-Kinase (PI5K) and PI(5)P via PI5P-4-Kinase (PI4K) (22). In mammalian 
cells, PI4P is a lot more abundant than PI5P. In our experiments, we indirectly reduced the 
PI(4,5)P2 levels by treatment with PI4K inhibitor PAO and PI5-kinase inhibitor quercetin, whose 
effects on RBL-2H3 cells are previously characterized (2). We find that the IgE receptors 
crosslinked in presence of these inhibitors localize in invaginations that are not accessible by 
surface labeling anti-Alexa 488 antibody, but are not cleaved from the plasma membrane, similar 
to the response in presence of F-actin polymerization inhibitors (Figure 2.15). Consistent with 
this, we also observe that pretreatment with PAO or quercetin substantially reduces the 
recruitment of F-actin to the activated FcεRI receptors complexes formed on the micropatterned 
ligand surfaces (Figure 2.16). Taken together, these results suggest that PI(4,5)P2 synthesis is 
important for recruitment of F-actin and other signaling partners that play important roles in 
fission of IgE containing endosomes from the plasma membrane.  
In summary, we have developed assays to probe the different states of IgE-FcεRI 
complexes during the process of internalization after crosslinking. Using these methods, we 
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show that FcεRI internalization depends on Syk kinase and F-actin polymerization. We also 
show that mild depletion of cholesterol prevents crosslinked IgE-FcεRI from pinching off from 
the plasma membrane. siRNA studies show that IgE internalization does not require clathrin, 
cortactin or HS1, but it is reduced by dynamin 2 knock down. We utilized micropatterned ligand 
surfaces to demonstrate the role of dynamin 2 in recruiting actin cytoskeleton to activated IgE 
receptor complexes. We also provide evidence that synthesis of PI(4,5)P2 is important for 
internalization of FcεRI.  
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Chapter 3
3
 
Spatially defined EGF receptor signaling using micro-patterned EGF arrays 
3.1 Introduction 
Epidermal growth factor receptor (EGFR) belongs to the tyrosine kinase family of 
receptors and is expressed at the plasma membrane of many cell types. EGFR signaling is known 
to be an important regulator of cellular responses, including proliferation, migration and 
apoptosis (1-4). EGFR signaling pathways are highly regulated and they have been a focus of 
many investigations. Numerous studies have shown that mutations in EGFRs can make them 
potent oncoproteins (4). Binding of EGF induces dimerization of EGFR that activates the kinase 
domains in the cytoplasmic segments with consequent transphosphorylation of tyrosine residues 
in this region of EGFR (1). These phosphorylated tyrosine residues act as docking sites for 
signaling adaptors, including Grb2, SHC and enzymes such as phospholipase C (PLC), thus 
linking EGFR to their downstream signaling partners. EGFR activation induces initiation of 
several signaling cascades, including those activating extracellular signal-regulating kinases 
(Erk) via H-Ras and Akt signaling through phosphatidylinositol 3-kinase (PI3K) activation. 
EGFR is also known to undergo internalization after stimulation with EGF (5).  
Although the series of signaling sequelae is well established, little is known about spatial 
aspects of signaling partner interactions with activated EGFR. Previous results with beads 
conjugated with EGF have shown that localized stimulation of EGFR leads to lateral propagation 
of EGFR activation at the plasma membrane (6), which means that EGFR is phosphorylated 
even a few micrometers away from the site of stimulation via these beads. The possibility that 
localization of receptor tyrosine kinases (RTKs) influences signaling consequences has been a 
                                                 
3
 Kirsten Bryant performed the western blotting experiments and paxillin knock down experiments, and she supplied 
the NIH-3T3 cells stably overexpressing EGFR. 
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focus of recent studies. There is evidence that EGFRs can continue signaling even from 
endosomes, and clathrin-mediated endocytosis of EGFR may play a role in the activation of Erk 
(7, 8). In contrast, another investigation revealed that reduction of endocytosis of EGFR 
following stimulation with EGF leads to more sustained activation of Akt and suggested that 
EGFR signaling occurs primarily at the plasma membrane (9). Recent evidence suggests that 
paxillin, an adaptor protein, participates in Erk activation and its subsequent nuclear 
translocation downstream of EGFR signaling (10), however, spatial aspects of the interaction of 
paxillin and other signaling partners like MEK and Erk with activated EGFR have not been 
elucidated. In addition, the role of F-actin in the recruitment of these signaling partners to 
activated EGFR on the plasma membrane remains unclear.  
We previously demonstrated that micropatterned ligand surfaces are useful tools to study 
the spatiotemporal aspects of FcεRI signaling (11, 12). We showed that FcεRI bound to anti-
DNP-IgE on the surface of mast cells is activated by DNP-liganded lipid bilayers, leading to 
recruitment of Lyn, a Src family kinase that initiates phosphorylation of FcεRI. In addition, we 
found that micron-scale recruitment of Lyn to FcεRI complexes involves the actin cytoskeleton, 
although tyrosine kinase activity associated with catalytic amounts of Lyn does not (11, 12). 
Previous studies with covalently attached EGF have shown that this configuration can stimulate 
EGFR, as detected by tyrosine phosphorylation of EGFR (13, 14). In addition, when EGF is 
covalently attached to a substrate, endocytosis of EGFR cannot occur, resulting in the formation 
of more stable EGFR signaling complexes at the plasma membrane. These results (13, 14) 
indicate that micron-scale patches of covalently attached EGF stimulate EGFR. 
Here, we utilize NIH-3T3 cells with stably expressed EGFR and micron-sized patches of 
surface-attached EGF to locally activate EGFR in well-defined geometrical patterns. Under these 
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conditions, we find that Ras, MAP kinase proteins, MEK and threonine-phosphorylated Erk 
(pErk) are recruited to the patterned EGFR signaling complexes at the plasma membrane in an 
actin cytoskeleton-dependent manner. We find that paxillin is recruited to these activated EGFR 
signaling complexes on the plasma membrane as tyrosine and serine phosphorylated species. We 
also observe colocalization of F-actin with these EGFR signaling clusters, but GFP-tagged 
integrin α5 is excluded. Our results provide strong evidence that an extended EGFR signaling 
complex is established by surface-attached EGF, and its stability depends on coupling to the 
actin cytoskeleton. 
 
3.2 Materials and Methods: 
3.2.1 Materials: 
All cell culture reagents, EGF, Lipofectamine 2000, and precast gels for blotting were 
from Invitrogen. FuGene HD was from Roche Applied Sciences. Alexa488-labeled goat anti-
mouse IgG1, Alexa 488-labeled goat anti-rabbit (H+L), Alexa488-phalloidin, Alexa647-labeled 
goat anti-mouse IgG (H+L), Alexa568-labeled streptavidin and N-terminal-labeled EGF-biotin 
were purchased from Invitrogen. Quercetin and phenylarsine oxide (PAO) were purchased from 
Sigma Aldrich. PP2 was purchased from Enzo LifeSciences. Cytochalasin D and Iressa were 
purchased from Calbiochem (EMD Chemicals). Rabbit anti-phospho-Erk, rabbit anti-phospho-
MEK, rabbit anti-C-terminal EGFR, and anti-phospho-Y1068-EGFR antibodies were purchased 
from Cell Signaling Corp. Rabbit anti-MEK antibody and FAK-HA cDNA construct were gifts 
from Dr. R.A. Cerione. Monoclonal anti-phosphotyrosine clone 4G10 was obtained from Upstate 
Cell Signaling Solutions (Millipore Co.). Anti-phospho-tyrosine paxillin was purchased from 
Santa Cruz Biotechnology. Dynamin 2-EGFP (15) cDNA was obtained from Dr. Mark McNiven 
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(Mayo Clinic). Rabbit anti-ezrin and anti-moesin antibodies were gifts from Dr. A. Bretscher 
(Cornell University). Integrin α5-EGFP and avian paxillin-EGFP cDNA constructs were gifts 
from Dr. A. Horwitz (University of Virginia). The EGFR-GFP construct from Dr. J. Koland has 
been described previously (16). Preparation of Lyn-mRFP was described previously (17). The 
cDNA construct of PLCγ1-EGFP (18) was a gift from Dr. Graham Carpenter, Vanderbilt 
University. GFP-H-Ras was a gift from Dr. Anne Kenworthy, Vanderbilt University. 
3.2.2 Cell Culture and Transfection 
 
RBL-2H3 cells were maintained in monolayer cultures and harvested with trypsin-EDTA 
(Invitrogen) 3–5 days after passage, as described previously (19). Chemical transfection of RBL-
2H3 cells was carried out using a complex of 2 μg cDNA with 8 μL Fugene-HD (Promega) in 
100 μL Opti-MEM (Life Technologies) that was added to plated cells in 1mL Opti-MEM per 
Mat-Tek well, followed by addition of phorbol dibutyrate (0.1μg/mL) as previously described 
(20).  
NIH-3T3 cells stably over-expressing wild type (wt)-EGFR, hereafter referred to as NIH-
3T3 (EGFR) cells, were cultured as monolayers in DMEM containing 10% (v/v) calf serum (CS) 
as described elsewhere (21). Briefly described, NIH3T3 cells were transfected with the wt-
EGFR-pkH3 vector, using FuGene HD (Roche). The transfection complex for NIH-3T3 cells 
was prepared similarly as for RBL-2H3 cells: plating the complex with the cells in DMEM 
(GIBCO) for 2 hours at 37°C, before washing away the complex and incubating with NIH-3T3 
media. Transfected cells were maintained in DMEM supplemented with 10% CS and 2μg/ml 
puromycin (Invitrogen). After 10–14 days, puromycin-resistant colonies were selected and 
subcultured in DMEM supplemented with 10% CS and 0.5 μg/ml puromycin. The clones were 
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then assessed for expression of EGFR. For use in experiments, NIH-3T3 (EGFR) (clone A13) 
cells were serum starved for 12-14 hours prior to harvesting. 
 
3.2.3 Microfabrication of patterned EGF surfaces.  
Surfaces with 1.5 to 4 μm features were patterned with a parylene layer as described 
previously (22, 23). An 8 x 8 mm parylene-patterned silicon substrate was prepared for 
functionalization by plasma cleaning for 5 minutes at room temperature under vacuum in a glass 
dish. The surface was rinsed with acetone and dried under nitrogen, followed by treatment with 
3-mercaptopropyltrimethyoxy silane (MPTS) for 30 minute at room temperature. The substrate 
was then washed with absolute ethanol (3x) and was incubated in 2 mM N-(-
maleimidobutyryloxy) succinimide (GMBS) in absolute ethanol for 1 hour at room temperature 
(24). The samples were rinsed with phosphate buffered saline (PBS, pH 7.4) and placed on 
parafilm, followed by incubation with 50 µg/mL Alexa568-streptavidin for 1 hour at room 
temperature. The substrates were thoroughly rinsed with PBS at room temperature, followed by 
incubation with 500 ng/mL EGF-biotin for 30 minutes at room temperature. The samples were 
rinsed thoroughly once more with PBS, and parylene was mechanically peeled away to yield 
patterned EGF on the substrate. For negative controls, incubation with EGF-biotin was omitted. 
Non-specific binding to the micro-patterned substrate is minimized by incubation with 1 mg/mL 
BSA for 5 minutes before plating the cells for experiments. 
 
3.2.4 Fluorescence Microscopy 
For experiments involving patterned EGF surfaces, ~100 l of cells suspended at a 
concentration of 0.5 x 10
6
 cells per mL in buffered salt solution (BSS:135 mM NaCl, 5.0 mM 
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KCl, 1.8 mM CaCl2, 1.0 mM MgCl2, 5.6 mM glucose and 20 mM Hepes pH 7.4) with 1 mg/ml 
BSA were added to a patterned substrate (8 × 8 mm) in the center of a 35-mm Petri dish with 
coverglass bottom (0.16–0.19 mm; MatTek Corp.) to minimize the volume of cell suspension 
utilized for each experiment. After 40 minutes of incubation at 37°C, cells were fixed with 4% 
paraformaldehyde in PBS for 20 minutes at room temperature followed by quenching with 10 
mg/ml BSA in PBS with 0.01% NaN3 (PBS/BSA). For immunofluorescence after fixation, cells 
were labeled with a primary antibody at room temperature for 1 hour in presence of 0.1% Triton-
X in PBS/BSA. After washing with PBS/BSA, a fluorophore-labeled secondary antibody was 
incubated with samples at room temperature for 1 hour in presence of 0.1% Triton-X in 
PBS/BSA. For labeling of F-actin, cells were incubated with 5 g/mL Alexa 488-phalloidin in 
PBS-BSA with 0.1% Triton-X for 30 minutes at room temperature prior to rinsing with PBS 
before inverting the chip for imaging using a Zeiss LSM 710 inverted microscope and a 63x Oil 
Plan-Apochromat lens. A DF 488/561/647 filter set was used to perform sequential 1/2/3 color 
imaging of the samples. The width of the focal plane was adjusted for optimal image quality. 
Quantification of colocalization was carried out by calculating Pearson’s cross-correlation 
coefficients for each cell using a Matlab code as described elsewhere (12). The equation used to 
calculate Pearson’s cross-correlation coefficient is:  
   
∑              
 ∑      
 ∑        
 
Where, xi and yi are the pixel intensity values for green and red channel, respectively, and x, y 
are the average values of xi and yi in the image. A mask is drawn around the cell of interest using 
a Matlab script, and ρ values are calculated for each individual cell. Statistical analyses were 
carried out by calculating the p values using Student’s t-test, and a value of p ≤ 0.05 was 
considered to be statistically significant. 
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3.2.5 Knockdown Experiments 
Small interfering RNA (siRNA) knockdown experiments were performed using 
siGENOME SMARTpool siRNA (Dharmacon) to knockdown mouse paxillin using a specific 
RNA sequence. A siRNA (ON-TARGETplus siCONTROL, Dharmacon) with the sequence 
UGGUUUACAUGUCGACUAA was used as the nonspecific (sham knock-down) control (12). 
The RNA interference oligonucleotides were transiently transfected in NIH-3T3 (EGFR) cells 
using Lipofectamine 2000, and the relative knockdown efficiency was determined using anti-
mouse paxillin antibody against paxillin by western blotting (BD Biosciences). 
 
3.2.6 Immunoblot Analysis 
Cells were lysed in 25mM Tris, 100mM NaCl, 1mM EDTA, 1% (v/v) Triton X-100, 1 
mM DTT, 1 mM sodium orthovanadate, 1 mM β-glycerol phosphate and 1µg/mL of leupeptin 
and aprotinin (lysis buffer), and whole-cell lysates (WCL) were recovered in the supernatant 
following microfuge centrifugation.  Protein concentrations of the WCL were determined using 
the Bio-Rad DC protein assay. WCL (40μg) were resolved by SDS/PAGE, and proteins were 
transferred to PVDF membranes. Membranes were blocked by 10% (w/v) BSA diluted in 20 
mM Tris, 135 mM NaCl, and 0.02% Tween 20 and incubated with the indicated primary 
antibodies diluted in the same buffer. The primary antibodies were detected with HRP-
conjugated anti-mouse IgG (GE Healthcare) followed by exposure to ECL reagent (Invitrogen). 
3.3 Results 
3.3.1 Cellular EGFR is activated on micropatterned EGF surfaces 
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Micropatterned surfaces, with A568-streptavidin covalently attached to silicon substrates, 
were prepared as described in Materials and Methods. Figure 3.1A schematically depicts the 
preparation of micropatterned surfaces via the parylene lift-off method, and cell association with 
these. In initial experiments, RBL-2H3 cells transiently transfected with GFP-tagged EGFR were 
incubated with silicon substrates containing micro-patterned, covalently attached A568-
streptavidin saturated with EGF-biotin. After 40 minutes at 37°C, we observed concentration of 
EGFR-GFP co-localized with the micron-sized EGF patches on the substrate, as detected via 
confocal fluorescence microscopy (Figure 3.1B). This clustering was not observed when the 
EGF-biotin was not attached to the micropatterned surfaces (data not shown).  
NIH-3T3 cells endogenously express a small amount of EGFR that is hard to detect at 
micro-patterned, immobilized EGF on silicon substrates (data not shown). To visualize EGFR 
more clearly, we used NIH-3T3 cells stably over-expressing EGFR, which is localized primarily 
at the plasma membrane in these cells (21). All further experiments were done using these cloned 
NIH-3T3 (EGFR) cells, so that transfection efficiency of EGFR is not a variable in our 
experiments. As shown in Figures 3.1B and 3.2A, we find that EGFR, labeled with an anti-
EGFR in these cells, is recruited to the EGF patches. Under these conditions, we detect robust 
tyrosine phosphorylation, colocalized with the clustered EGFR, most likely due to the EGFR 
kinase activity (Figure 3.2A – blue channel). The clustering of EGFR and enhanced tyrosine 
phosphorylation depends on the presence of EGF in the patterns (Figure 3.2A). This tyrosine 
phosphorylation can be detected as early as 10 minutes after plating in >90% of the imaged cells, 
and it increases in intensity with times up to 40 minutes after plating at 37
o
C (data not shown).  
Recruitment of signaling partners to micron-sized patches can be quantified by 
calculation of Pearson’s cross-correlation coefficient, which evaluates the spatial coincidence of 
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two distinct labels. Consistent with our qualitative observations in confocal images, we find that 
the Pearson’s cross-correlation coefficient is ~0.7 for EGFR localized to EGF patterns, and ~ 
0.05 in absence of EGF-biotin at these patterns (Figure 3.2C). Similarly, the Pearson’s 
coefficient for tyrosine phosphorylation at the patterns is ~0.8 in presence of EGF and ~ 0.06 in 
its absence.  
We also detect tyrosine phosphorylation of EGFR specifically at tyrosine 1068 by 
labeling with an anti-phospho-tyrosine 1068 EGFR antibody (Figure 3.3A). Iressa is a potent 
inhibitor of the tyrosine kinase activity of EGFR (25), and when NIH-3T3 (EGFR) cells are 
serum starved overnight and plated in the presence of 10 µM Iressa for 40 minutes at 37°C on 
patterned EGF substrates, there is no detectable phosphorylation of EGF receptors at Tyr-1068 in 
EGF patterns (Figure 3.3A). None-the-less, in presence of Iressa, EGFR is recruited to the EGF 
patterns, even though there is no enhancement or concentration of tyrosine phosphorylation as 
detected by a more general anti-phospho-tyrosine antibody (Figure 3.3B). These results show 
that micro-patterned, immobilized EGF binds to and clusters EGFRs on the surface of the cells, 
but receptor activation and its consequent tyrosine phosphorylation depend on the EGFR kinase 
activity.  
3.3.2 Paxillin is recruited and phosphorylated within activated EGFR clusters at the 
plasma membrane: 
Paxillin, a multi-domain adaptor protein, is known to participate in integrin mediated 
signaling as a part of focal adhesions (26). In this role, it interacts with several actin cytoskeleton 
regulating proteins, including vinculin and talin (26, 27). We previously found that paxillin is 
recruited to clustered IgE receptor complexes, and it contributes to the regulation of IgE receptor 
signaling (12). Prior studies have shown that paxillin plays an important role in the activation of 
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Figure 3.1: EGFR binds to patterned EGF: A) A schematic showing fabrication of EGF 
patterned surfaces and subsequent incubation of cells on the patterned substrate. B) RBL-
2H3 cells transiently transfected with EGFR-GFP (top panel), incubated on covalently 
immobilized EGF patterns for 40 minutes at 37°C, prior to fixation by 4% 
paraformaldehyde for 20 minutes at room temperature. The bottom panel shows NIH-3T3 
cells stably over expressing wt-EGFR, plated on micro-patterned EGF surfaces for 40 min 
at 37°C. EGFR is labeled with an anti-EGFR primary, and an A488 tagged secondary 
antibody. (Scale bar: 20 µm) 
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Figure 3.2 EGFR is activated in a ligand dependent manner on patterns: A) NIH-3T3 
cells stably over-expressing EGFR were plated onto micro-patterned, covalently 
immobilized EGF (labeled by A568-streptavidin – red channel), for 40 minutes at 37°C 
prior to fixation with paraformaldehyde. The same conditions were used for incubating the 
cells in all the subsequent experiments, unless specified otherwise. The cells were 
subsequently immunolabeled with anti-EGFR primary antibody and A488 tagged 
secondary antibody (green channel). These cells were also immunolabeled with an anti-
phospho-tyrosine primary antibody and A647 tagged secondary antibody (blue channel). 
The bottom panel shows the NIH-3T3 (EGFR) cells plated on micro-patterned surfaces 
without EGF-biotin bound to the covalently immobilized A568-streptavidin. B) 
Quantification of colocalization by calculating Pearson’s correlation coefficients for green 
channel with red channel, and blue channel with red channel, as described in Materials and 
Methods. Error bars represent SEM; **** indicates p ≤ 0.0001, n > 40 cells over 3 
independent experiments. Scale bar: 20 µm 
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Erk after EGFR stimulation (10). We examined the distribution of paxillin-GFP in NIH-3T3 
(EGFR) cells under conditions of EGFR clustering at the patterns, and we observed that paxillin-
GFP is visibly concentrated at these patterned features (Figure 3.4A, top panel). This 
concentration at patterned surfaces is not observed in the absence of EGF-biotin (Figure 3.4A, 
middle panel). Quantification of this co-localization using Pearson’s cross-correlation coefficient 
gives a value of ~0.25 for paxillin-GFP colocalization with A568-streptavidin patches when EGF 
is present on the surface, substantially higher than the value when EGF-biotin is absent from the 
surface (~0.05, Figure 3.4B). In addition, this recruitment of paxillin-GFP is also inhibited by 
treatment of cells with EGFR kinase inhibitor Iressa, demonstrating its dependence on tyrosine 
kinase activation (Figure 3.4A, bottom panel, and Figure 3.4B).  
Paxillin has several sites of phosphorylation that mediate its binding to several different 
proteins (28). Paxillin is phosphorylated at Tyr 31 and Tyr118 by Src kinase (29), and at Ser 83 
(30) and Ser 126 (31) by Erk kinase. We find that paxillin recruited to clustered EGFR is 
phosphorylated at Tyr 31 and/or 118 residues, identified by labeling with anti-paxillin Tyr 118 
antibody (Figure 3.5). Paxillin recruited to clustered EGFR is also phosphorylated at Ser 126 as 
detected by labeling with anti-paxillin phospho-Ser126 antibody (Figure 3.5A). Quantification of 
these results using Pearson’s analysis shows that there is significant association of tyrosine 
phosphorylated paxillin (~0.41) and serine phosphorylated paxillin (~0.28) on EGF patterns 
(Figure 3.5B).  
To examine the dependence of paxillin recruitment and phosphorylation on Src kinase 
activity, we tested the effect of PP2, a well-known Src kinase inhibitor. As expected, tyrosine 
phosphorylation of recruited paxillin is inhibited by pretreatment with 20 µM PP2. However, 
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Figure 3.3: Activation, but not recruitment of EGFR to EGF patches, depends on 
EGFR kinase activity: A) NIH-3T3 (EGFR) cells were plated onto micro-patterned EGF 
surfaces (red channel) for 40 minutes at 37°C prior to fixation. These cells were then 
immunolabeled with anti-phospho-Tyr-1068 EGFR primary antibody and A488 tagged 
secondary antibody (green channel). Bottom panel: NIH-3T3 (EGFR) cells pretreated with 
10 μM Iressa overnight and plated in presence of 10 μM Iressa  on micro-patterned EGF 
surfaces. B) NIH-3T3 (EGFR) cells plated on micro-patterned EGF surfaces without (top 
panel) and with (bottom panel) Iressa pretreatment. Cells were then immunolabeled with 
anti EGFR antibody (A488 – green channel) and 4G-10 anti-phospho-Tyr antibody (A647 
secondary – blue channel). Scale bar: 20 µm 
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Figure 3.4: Paxillin is recruited to the EGF patterns in a ligand dependent manner: A) 
NIH-3T3 (EGFR) cells transiently transfected with paxillin-GFP (green channel), were 
plated on micro-patterned, covalently attached A568-streptavidin (red channel) surfaces 
with EGF-biotin (top panel), or without EGF-biotin (middle panel). The bottom panel 
shows the NIH-3T3 (EGFR) cells transiently transfected with paxillin-GFP and pretreated 
with 10 μM Iressa overnight, prior to incubation on micropatterned EGF surfaces. B) 
Quantification with Pearson’s cross correlation coefficients to compare red and green 
channels; N > 20 cells for each sample at least 2 independent experiments. Error bars 
represent SEM; **** indicates p ≤ 0.0001, *** indicates p ≤ 0.001. Scale bar: 20 µm. 
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Figure 3.5 Paxillin is phosphorylated in EGFR signaling complexes at the plasma 
membrane: A) NIH-3T3 (EGFR) cells transiently transfected with paxillin-EGFP (top 
panel, green channel) were incubated with micro-patterned EGF surfaces (red channel). 
NIH-3T3 (EGFR) cells, incubated with micropatterned EGF surfaces prior to fixation, were 
immunolabled with anti-phospho-Tyr 118 anti-paxillin antibody (green channel, middle 
panel) or anti-phospho-Ser paxillin antibody (green channel, bottom panel). B) Co-
localization of paxillin with micro-patterned EGF is quantified by Pearson’s cross 
correlation coefficients between green and red channels; N > 30 cells per sample, from at 
least 2 independent experiments. Error bars represent SEM. Scale bar: 20μm 
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PP2 does not inhibit recruitment of paxillin-GFP or paxillin phosphorylation at serine 
residues (Figure 3.6A, B). Quantification of cross-correlation between these labels and 
Alexa568-streptavidin shows very low Pearson’s correlation coefficient values for tyrosine 
phosphorylated paxillin and EGF patterns in presence of PP2. In contrast, a slight enhancement 
in colocalization of paxillin-GFP and serine phosphorylated paxillin is detected with EGF 
patterns under these conditions (Figure 3.6C). Together, these results indicate that paxillin is 
recruited to clustered EGFR at the plasma membrane in a ligand-dependent and EGFR kinase 
activity-dependent manner. Furthermore, recruited paxillin is phosphorylated on tyrosine 
residues by Src, and paxillin recruitment and serine phosphorylation do not depend on Src 
activity. 
3.3.3 F-actin is recruited to the activated EGFR complexes, whereas α5 integrin is 
excluded. 
A previous study showed that F-actin co-localizes with IgE receptors clustered in micron-
scale patterns (11). Similarly, we found that F-actin labeled with Alexa488-phalloidin in NIH-
3T3(EGFR) cells concentrates at with the patterned EGF(Figure 3.7A). This clustering of F-actin 
can be observed as soon as 10 minutes after plating the cells and is maximal after 30 minutes of 
plating. Inhibition of actin polymerization by 2 M cytochalasin D during cell attachment 
substantially reduces this local accumulation. Quantification by Pearson’s analysis shows 
substantial co-localization of F-actin with patterned EGF in the absence of cytochalasin D 
(Figure 3.7B). We evaluated whether ezrin or moesin, which connect the actin cytoskeleton to 
the plasma membrane under some conditions (32), become concentrated in the location of 
clustered EGFR. We detected no such concentration of these labeled proteins in three separate 
experiments (Figure 3.7A and B).  
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Because paxillin and F-actin are often concentrated in focal adhesions as modulated by 
integrins (33), we examined whether integrins are also localized to the EGFR signaling 
complexes. Integrin α5 is the most abundant integrin alpha subunit in NIH-3T3 cells (34), and 
we expressed a GFP-tagged form of this protein. As shown in Figure 3.8, we find that this 
protein is excluded from EGFR clusters on the patterned surfaces. In > 80% cells, we find that 
integrin α5-GFP is depleted from the regions of patterned EGF. This contrasts with F-actin and 
paxillin, which are concentrated in these regions. This exclusion of integrin α5-GFP is observed 
even in the presence of cytochalasin D, suggesting that it is independent of focal adhesion 
complexes (data not shown). 
 
3.3.4 The Erk signaling pathway is recruited to patterned EGF.  
EGFR activated by EGF initiates a signaling cascade leading to activation of Ras (Figure 
1.5), MEK, and Erk (35, 36). EGFR phosphotyrosine residues are the docking sites for binding 
of Grb2, which in turn activates son of sevenless (SOS), a guanine nucleotide exchange factor 
(GEF) that activates Ras (37). To investigate whether proteins in the Erk signaling pathway co-
localize with clustered, activated EGFR, GFP-H-Ras was transiently expressed in NIH 3T3 
(EGFR) cells, and these cells were plated on EGF-patterned surfaces for 40 minutes at 37°C. 
Confocal imaging shows concentration of GFP-H-Ras fluorescence with patterned EGF  in 
>95% of imaged cells (Figure 3.9A). We see similar recruitment of transiently transfected GFP-
N-Ras to these patterned EGF (data not shown). This recruitment of GFP-H-Ras to the patterned 
EGF is not reduced by 20 μM PP2, indicating no dependence on Src kinase activity (data not 
shown).  
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Figure 3.6: Tyrosine phosphorylation, but not recruitment of paxillin, depends on Src 
kinase: A) NIH-3T3 (EGFR) cells, transiently transfected with paxillin-GFP (green 
channel) and pretreated with 20 μM PP2, a Src kinase inhibitor, were incubated with 
micropatterned EGF surfaces (red channel).  B) NIH-3T3 (EGFR) cells, pretreated with 20 
μM PP2 and incubated with micropatterned EGF surfaces and subsequently immunolabeled 
with anti-phospho-Tyr 118 anti-paxillin antibody (green channel, top panel) or anti-
phospho-Ser paxillin antibody (green channel, bottom panel). C) Quantification of 
colocalization by calculation of Pearson’s cross correlation coefficients for green channel 
with red channel, N > 20 cells, from at least 2 independent experiments. Error bars 
represent SEM; *** indicates p ≤ 0.001. Scale bar: 20 μm. 
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Figure 3.7: F-actin co-redistributes with EGFR complexes on the plasma membrane: 
A) NIH-3T3 (EGFR) cells were plated onto micropatterned EGF surfaces (red channel) and 
immunolabeled with A488-phalloidin (green channel, top panel), anti-moesin (middle 
panel), or anti-ezrin (bottom panel). B) Quantification of colocalization by calculation of 
Pearson’s cross-correlation coefficients for green channel with red channel, N > 20 cells 
per sample, from 2 independent experiments. Error bars represent SEM; **** indicates p ≤ 
0.0001, *** indicates p ≤ 0.001. Scale bar: 20 μm. 
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Figure 3.8: Integrin α-5 is excluded from EGF-bound EGFR signaling complexes: A) 
NIH-3T3 (EGFR) cells transiently transfected with integrin α5-EGFP (green channel) were 
plated on micro-patterned A568-streptavidin (red channel) with EGF-biotin (top panel) or 
without EGF-biotin (bottom panel). B) Quantification by calculation of Pearson’s cross-
correlation coefficients for green channel with red channel. N > 20 cells, in 2 independent 
experiments. Error bars represent SEM; *** indicates p ≤ 0.001, ** indicates p ≤ 0.01. 
Scale bar: 20 μm. 
 
  
134 
 
  
135 
 
Figure 3.9: Proteins involved in the Erk signaling cascade -- Ras, MEK and Erk -- co-
redistribute with EGFR signaling complexes on plasma membrane: A) NIH-3T3 
(EGFR) cells transiently transfected with GFP-H-Ras (green channel, top panel), were 
plated on micro-patterned EGF surfaces. NIH-3T3 (EGFR) cells were plated on micro-
patterned EGF surfaces, and after fixation they were immunolabeled with anti-MEK (green 
channel, middle panel) or anti-phospho-Erk (green channel, bottom panel) antibodies, 
followed by A488 labeled secondary antibodies. B) Quantification by calculation of 
Pearson’s cross-correlation coefficients of green channel with red channel; N > 30 cells 
from 3 independent experiments. Error bars represent SEM; *** indicates p ≤ 0.001, ** 
indicates p ≤ 0.01. Scale bar: 20 μm. 
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Similar to results with GFP-H-Ras, we also observed colocalization of MEK and pErk 
with the patterned EGF  using specific antibodies post fixation (Figure 3.9A). Quantitative 
analysis of co-localization by cross-correlation analysis shows limited but statistically significant 
recruitment of these more downstream partners in the Erk activation pathway in a ligand-
dependent manner (Figure 3.9B).  In addition to their recruitment to clustered EGFR, a 
noticeable fraction of the fluorescent label for MEK and pErk becomes localized in the nucleus 
under these conditions of cell activation (observed with z-sectioning; data not shown).  These 
results provide evidence for the formation of a macromolecular signaling complex colocalized 
with clustered EGFR on the patterned surface that includes all of the principal proteins in the Erk 
signaling cascade. 
3.3.5 Recruitment of EGFR signaling partners to patterned EGF depends on the actin 
cytoskeleton. 
Our laboratory previously reported actin cytoskeleton-dependent recruitment of Lyn to 
clustered IgE on patterned ligands, even though catalytic amounts of Lyn required for 
phosphorylation of FcεRI is not inhibited by cytochalasin D (11). In the present experiments, we 
observe that recruitment of paxillin and p-Erk to patterned EGF is inhibited by cytochalasin D 
(Figure 3.10A), even though cytochalasin D does not inhibit the recruitment or activation of the 
EGFR to EGF on patterns, as observed by localized, concentrated labeling of EGFR and 
phosphotyrosine  detected by 4G10 mAb (Figure 3.10A – blue channel). We further found that 
treatment with cytochalasin D does not inhibit phosphorylation of recruited EGFR at tyrosine 
1068, consistent with a lack of cytoskeletal dependence of these early events under these 
conditions (data not shown). We did not detect recruitment of H-Ras and MEK to patterned EGF 
in presence of cytochalasin D (data not shown).  
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Quantification by Pearson’s correlation coefficient shows that there is a significant 
decrease in the colocalization of p-Erk and paxillin with patterned EGF in presence of 
cytochalasin D (Figure 3.10B). In a previous study, cytochalasin D did not inhibit activation of 
Erk in Rat 1a fibroblasts by soluble EGF (38). In our experiments with cytochalasin D, we 
observe that stimulation of surface-attached NIH-3T3 (EGFR) cells by soluble EGF (50 ng/mL) 
caused a partial decrease in the activation of Erk, as compared to cells stimulated in absence of 
cytochalasin D, as detected by western blotting (Figure 3.10C). Quantification of this Erk 
phosphorylation stimulated by soluble EGF indicates ~50% inhibition due to cytochalasin D 
(Figure 3.10D). This suggests that the actin cytoskeleton stabilizes the EGFR signaling 
complexes formed by either soluble or immobilized EGF and thereby participates in Erk 
activation due to stimulation of EGFR. 
3.3.6: Dynamin 2, PLCγ-1, and Lyn are recruited to patterned EGF: 
Dynamin 2 is a GTPase that is commonly implicated in internalization of receptors on 
cell surfaces by facilitating fission of the forming endosomes from the plasma membrane (39). In 
Chapter 2, we showed that dynamin 2 plays a role in the organization of actin cytoskeleton at the 
sites of IgE receptor endocytosis. Here, we find that dynamin 2-GFP expressed in NIH-3T3 
(EGFR) cells is recruited to patterned EGF in >90% of the dynamin 2-GFP expressing cells 
(Figure 3.11A). This recruitment is not inhibited by cytochalasin D (data not shown), similar to 
previous observations with IgE receptors concentrated in micron-scale patterns (Chapter 2, 
Figure 2.13)  
Phospholipase C1 (PLCγ1) is an enzyme that mediates hydrolysis of PI(4,5)P2 to 
inositol 1,4,5 triphosphate (IP3) and diacylglycerol (DAG), and it was previously shown to bind 
directly to activated EGFR via its tandem SH2 domains (40).  NIH-3T3 (EGFR) cells transiently 
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Figure 3.10: Recruitment of pErk and paxillin depend on F-actin polymerization: A) 
NIH-3T3 (EGFR) cells transiently transfected with paxillin-EGFP (top panel, green 
channel) were pretreated with 2 μM cytochalasin D prior to incubation on the micro-
patterned EGF surfaces. NIH-3T3 (EGFR) cells incubated with micro-patterned EGF 
surfaces in presence of 2 μM cytochalasin D and immunolabeled with anti-phospho-Erk 
primary and an A488 tagged secondary antibody (green channel, bottom panel). B) 
Pearson’s cross-correlation coefficient of green channel with red channel. N > 30 cells over 
2 independent experiments. C) Surface adhered NIH-3T3 (EGFR) cells, treated with or 
without cytochalasin D, EGF are solubilized and prepared for western blotting. Proteins 
separated on SDS gels were labeled with anti-EGFR, anti-phospho-Tyr-1068, and anti-
phospho-Erk antibodies. D) Calculated intensities of phospho-Erk bands from the western 
blots over 3 independent experiments. The intensities were normalized for each individual 
experiment (where pErk band intensity of sample stimulated with EGF in absence of 
cytochalasin D was normalized to 1, and the remaining intensities were normalized 
accordingly), where band intensity obtained for EGF treatment in absence of cytochalasin 
D was normalized to 1. Error bars represent SEM; *** indicates p ≤ 0.001, * indicates p ≤ 
0.05.  Scale bar: 20 μm. 
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Figure 3.11: PLCγ-1, Dynamin2, and Lyn are recruited to patterned EGF: NIH-3T3 
(EGFR) cells were transiently transfected with dynamin 2-GFP (top panel) or PLCγ-GFP 
(middle panel) and plated on micro-patterned EGF surfaces (red channel) prior to fixation. 
NIH-3T3 (EGFR) cells transiently transfected with Lyn-mRFP (bottom panel, red channel) 
were incubated on EGF-biotin bound micro-patterned FITC-streptavidin (bottom panel, 
green channel) prior to fixation. Scale bar: 20 μm. 
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transfected with a GFP-tagged construct of PLCγ-1 show recruitment of this enzyme to patterned 
EGF (Figure 3.11A) in a ligand-dependent manner (data not shown). 
Sen et al. (2010) previously showed that Src kinase phosphorylates paxillin at Tyr118 as 
a consequence of EGFR activation in prostate cancer cells (10). To investigate the association of 
a Src family kinase with EGF patterns, we transiently transfected NIH-3T3(EGFR) cells with 
Lyn-mRFP and examined its localization using EGF-biotin bound to FITC-streptavidin. As 
shown in Figure 3.11, panel 3, we observe concentration of Lyn-mRFP with the patterns in 
~60% of the positively transfected cells. This suggests that Src family kinases can be recruited to 
activated EGFR complexes, providing a mechanism by which they can mediate phosphorylation 
of Tyr 118 in paxillin, also associated with the activated EGFR signaling complexes.  
 
3.3.7 Inhibitors of PI(4,5)P2 synthesis interfere with recruitment of F-actin, Erk, and 
dynamin 2 to pattern-localized EGFR complexes: 
It is now well-established that PI(4,5)P2 plays multiple roles in regulating cell signaling 
(41). We recently showed that two inhibitors of phosphoinositide synthesis, PAO and quercetin, 
effectively inhibit multiple consequences of IgE receptor signaling in mast cells, including 
stimulated Ca
2+
 mobilization, cell morphological changes, and endocytosis of FcRI (42). We 
also found that these compounds inhibit recruitment of F-actin to IgE receptor complexes 
localized to micro-patterned antigen (Chapter 2). In NIH-3T3 (EGFR) cells, we find that 
pretreatment of cells with 2 μM PAO or 20 μM quercetin leads to substantial reduction in F-actin 
recruitment to EGF patterns, as detected by A488-phalloidin labeling (Figure 3.12A and B). In 
addition, treatment with PAO or quercetin reduces the recruitment of p-Erk at EGFR signaling 
complexes on patterned EGF surfaces (Figure 3.13A and B).  
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We previously provided evidence for a role for dynamin 2 in the organization of the actin 
cytoskeleton at the sites of micro-patterned FcεRI receptor complexes (Chapter 2). Dynamin 2 is 
known to have a PI(4,5)P2-binding pleckstrin homology (PH) domain (43), and this could be 
relevant for this role. To investigate this issue with regard to the pattern-localized EGFR 
signaling complexes, NIH-3T3 (EGFR) cells were transiently transfected with dynamin2-GFP, 
then briefly pretreated with 2 µM PAO or 20µM quercetin prior to plating on EGF patterned 
surfaces. As shown in Figure 3.14, these compounds prevent the concentration of dynamin 2 at 
EGF patterns. (observed for > 95% of the imaged cells). These results suggest that 
phosphoinositides play a role in the co-localization of dynamin 2 with the clustered EGFR bound 
to patterned EGF. 
 
3.3.8 Paxillin is required for recruitment of p-Erk to the EGF patterns, but not its 
activation by soluble EGF. 
A previous study showed that paxillin plays a role in the phosphorylation of Erk after 
activation of EGFR as well as androgen receptors (AR) in prostate cancer cells (10). Paxillin has 
been previously shown to participate in integrin-mediated activation of Erk by stabilizing the 
signaling complex (44). We utilized siRNA knock down of paxillin in NIH 3T3 (EGFR) cells to 
assess its role in Erk activation by patterned EGF. Under our conditions, >95% knock down is 
achieved 48 hrs after transfection (Figure 3.15A,B). Knock down of paxillin does not inhibit 
enhanced tyrosine phosphorylation stimulated by patterned EGF or recruitment of F-actin to 
these clusters, early events in this response (Figure 3.15C). By comparison, this knock down 
reduces co-localization of p-Erk with the patterned EGF (Figure 3.16A,B), a later response in the 
signaling sequelae. Knock down of paxillin does not inhibit Erk activation in NIH-3T3(EGFR) 
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cells by soluble EGF, as detected by western blotting (Figure 3.16C). These results indicate some 
differences in the signaling requirements for paxillin in these cells depending on the physical 
presentation of the stimulus. Surprisingly, paxillin knock down does not inhibit recruitment of 
GFP-H-Ras to patterned EGF (Figure 3.17), despite its inhibiting p-Erk recruitment  occurring 
more down-stream in this MAP kinase cascade. These results suggest that paxillin plays a 
nuanced role in regulating the activation of this cascade by surface-associated EGF. 
 
3.4 Discussion: 
Receptor tyrosine kinases are key regulators of cellular processes such as proliferation, 
migration, and differentiation (1). Upon binding its ligand EGF at its extracellular domain, 
EGFR dimerizes, leading to transphosphorylation of the tyrosine residues in the cytoplasmic 
region of the receptor. Signal transduction propagates through the recruitment via 
phosphotyrosine binding to adaptor proteins such as Grb2 and enzymes such as PLCγ-1. These 
recruited adaptor proteins activate downstream signaling cascade involving Ras, MEK, Erk and 
PI3-kinase-dependent activation of Akt (Figure 3.18). The signaling pathways leading to 
activation of these proteins are well-established (37, 45), but less is known about the spatial 
redistribution of these proteins with activated EGFR at the plasma membrane. Micro-patterned 
ligand arrays have been a valuable tool to study the interactions of cytoplasmic and membrane 
bound proteins with ligand-activated plasma membrane receptors. We previously utilized these 
surfaces to probe the recruitment of signaling partners of activated FcεRI receptor (11, 12). In 
that situation, the size of the ligand – dinitrophenyl (DNP) (~ 266 Da) was substantially smaller 
than EGF (~6500 Da) in the present case (2).  
There has been prior evidence that covalently immobilized EGF stimulates tyrosine 
phosphorylation of proteins in chinese hamster overy (CHO) cells over-expressing EGFR   
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Figure 3.12 PI(4,5)P2 synthesis is involved recruitment of F-actin to EGFR signaling 
complexes: A) NIH-3T3 (EGFR) cells were pretreated with 2 μM PAO (middle panel) or 
20 μM quercetin (bottom panel) or not treated (control; top panel) prior to plating on 
micro-patterned EGF surfaces. The cells were labeled with A488-phalloidin after fixation. 
B) Pearson’s cross-correlation coefficient of green channel with red channel; N > 30 cells, 
for at least 2 independent experiments. Error bars represent SEM; **** indicates p ≤ 
0.0001, *** indicates p ≤ 0.001. Scale bar: 20 μm. 
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Figure 3.13: PI(4,5)P2 synthesis is involved in recruitment of pErk to EGFR signaling 
complexes A) NIH-3T3 (EGFR) cells were pretreated with 2 μM PAO (middle panel) or 
20 μM quercetin (bottom panel) or not treated (control; top panel) prior to plating on 
micro-patterned EGF surfaces. The cells were immunolabeled with phospho-Erk primary 
and A488 tagged secondary antibody after fixation. B) Pearson’s cross-correlation 
coefficients of green channel with red channel; N > 30 cells from 2 independent 
experiments. Error bars represent SEM, **** indicates p ≤ 0.0001, *** indicates p ≤ 0.001. 
Scale bar: 20 μm. 
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Figure 3.14: PI(4,5)P2 synthesis is involved in the recruitment of dynamin 2 to 
patterned EGF: NIH-3T3 (EGFR) were cells transiently transfected with dynamin 2-GFP, 
pretreated with 2 μM PAO (middle panel) or 20 μM quercetin (bottom panel) or control 
(untransfected, top panel) prior to plating on micro-patterned EGF surfaces. Scale bar: 20 
μm. 
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Figure 3.15: Paxillin knockdown does not inhibit recruitment of F-actin or enhance 
tyrosine phosphorylation at patterned EGF: A) Plated NIH-3T3 (EGFR) cells were 
transfected with 80 pmol paxillin siRNA and lysed after 24, 48, 72, 96 hours to prepare 
samples for western blotting. Bands were labeled with anti-paxillin antibody. B) Plated 
NIH-3T3 (EGFR) cells were transfected with 80 pmol control siRNA  or 80 pmol paxillin 
siRNA, treated with 100 ng/mL soluble EGF for 30 minutes 48 hours after the siRNA 
treatment. The cells are subsequently lysed and samples were prepared for western blotting. 
C) NIH-3T3 (EGFR) cells were treated with paxillin siRNA or control siRNA for 48 hours 
prior to harvesting and plating on micro-patterned EGF surfaces (red channel). They were 
subsequently fixed and labeled with A488-phalloidin (green channel) or anti-phospho-
tyrosine (4G-10) antibodies (blue channel). Scale bar: 20 μm. 
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Figure 3.16: Recruitment of Erk to patterned EGF is affected by paxillin siRNA 
knockdown: A) NIH-3T3 (EGFR) cells were treated with paxillin siRNA or control 
siRNA for 48 hours prior to harvesting and plating on micro-patterned EGF surfaces (red 
channel). They were subsequently fixed and immunolabeled with phospho-Erk antibody 
(green channel), and anti-phospho-tyrosine (4G-10) antibodies (blue channel).   B) 
Pearson’s cross-correlation coefficients of green channel with red channel. N > 30 cells 
from 2 independent experiments (p value = 0.0298). C) Plated NIH-3T3 (EGFR) cells were 
transfected with 80 pmol paxillin siRNA or 80 pmol control siRNA and lysed after 48 
hours to prepare samples for western blotting. Bands were labeled with anti-paxillin 
antibody (top lane), anti-phospho-Erk antibody (middle lane) or anti-Erk (bottom lane). 
Error bars represent SEM; * indicates p ≤ 0.05. Scale bar: 20 μm. 
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Figure 3.17: Recruitment of H-Ras is not inhibited by paxillin siRNA treatment: A) 
Plated NIH-3T3 (EGFR) cells were transfected with 80 pmol paxillin siRNA or control 
siRNA; they were transfected (or not) with GFP-H-Ras 24 hours after the initial siRNA 
treatement. The cells were then lysed after 48 hours after the siRNA treatment to prepare 
samples for western blotting. B) NIH-3T3 (EGFR) cells transfected with paxillin siRNA 
(bottom panel) or control siRNA (top panel) prior to transfection with GFP-H-Ras, and 
then harvested and plated on micro-patterned EGF surfaces (red channel). C) Pearson’s 
cross-correlation coefficient of green channel with red channel. N > 30 cells from 2 
independent experiments. Error bars represent SEM; n.s indicates non-significant statistical 
difference. Scale bar: 20 μm. 
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(13, 46) and in breast cancer BT-20 cells (14). These previous studies utilized EGF 
micropatterned on surfaces with feature sizes of dimensions ~ 10 μm - 100 μm to investigate the 
activation of EGFR by tyrosine phosphorylation and found that cells cultured on surface-attached 
EGF show higher growth in comparison to the cells plated on surfaces without surface-attached 
EGF.  Our experiments utilize patches of EGF-biotin, tightly bound to covalently attached A568-
streptavidin, with the sub-cellular dimension of 1 μm – 2.5 μm to demonstrate that EGFR 
accumulates at these EGF patches, such that distinctly clustered EGFR is observed within 
individual cells (Figure 3.2). Initially, we found that RBL-2H3 cells transiently transfected with 
GFP tagged EGFR and incubated on substrates micro-patterned with non-covalent surface 
adsorbed rhodamine-EGF caused endocytic removal of rhodamine-EGF from the surface after 
binding to EGFR (data not shown). This demonstrates the importance of covalently attaching the 
ligand on micro-patterned surfaces to visualize robust recruitment of EGFR, and to form 
spatially resolved clusters (Figure 3.2). We also specifically observed that EGFR recruited to 
patterned EGF is tyrosine phosphorylated at Tyr 1068 residue (Figure 3.3), which is consistent 
with previous observations when EGFR is stimulated with soluble EGF (47). Upon binding to 
soluble EGF, EGFR is known to dimerize prior to transphosphorylation in its cytoplasmic 
domains (1). Our results indicate that the local concentration of EGF in micro-patterned surfaces 
is sufficiently high, such that EGFRs undergo transphosphorylation leading to initiation of 
downstream signaling. This stimulated tyrosine phosphorylation of EGFR depends on EGFR 
kinase activity and is inhibited by treatment with 10μM Iressa – a known inhibitor for EGFR 
kinase activity (Figure 3.3A). We note that pretreatment of cells with Iressa does not inhibit the 
interaction of EGF receptors with immobilized EGF patches (Figure 3.3B), and this implies that 
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EGFR kinase activity is not required for EGFR binding with micron-sized EGF patches, but it is 
required for its activation. 
Activation of EGFR initiates a signaling cascade that leads to activation of Ras, which is 
known to be involved in the activation of Raf kinase (48, 49). Our results demonstrate 
recruitment of GFP-H-Ras to the clustered EGFR on the plasma membrane (Figure 3.9). This 
result makes it likely that Ras directly or indirectly associates with clustered EGFR at the plasma 
membrane. Ras activates Raf, which further activates MEK, which in turn phosphorylates Erk, to 
form a part of the MAP kinase cascade (50, 51). A previous study showed that, post activation, 
Erk and MEK are translocated as a complex into the nucleus to activate gene transcription, which 
lead to cell functions such as proliferation and cell division (52). Our experiments show that 
MEK and Erk interact with the EGFR at the plasma membrane of the cells that are clustered with 
micropatterned, immobilized EGF (Figure 3.9). Previously, these interactions have been hard to 
visualize due to limitations in optical resolution and to EGFR endocytosis after activation by 
EGF. To our knowledge, this is the first evidence of interaction of Erk with activated EGFR at 
the plasma membrane. This result demonstrates that macromolecular complexes of EGFR 
formed on the plasma membrane can activate Erk co-localized with these complexes, along with 
other members of this MAP kinase cascade, Ras and MEK. 
Recent studies have pointed towards a role for paxillin in EGFR signaling (10, 53). We 
studied the involvement of paxillin, using micropatterned EGF surfaces and find that paxillin-
GFP in NIH-3T3 cells interacts with the clustered EGFR at the plasma membrane in a process 
that depends on EGFR kinase activity (Figure 3.4). Paxillin is known be phosphorylated on Tyr 
31 and 118 residues by Src kinase, and on Ser 83 and 126 residues by Erk (28). In agreement, we 
observe the phosphorylation of paxillin recruited to EGFR signaling complexes at plasma 
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membrane on Tyr 31 and Ser 126 residues by labeling with anti-phospho-paxillin antibodies 
(Figure 3.5). Consistent with the tyrosine phosphorylation of paxillin by Src (29), we observe 
recruitment of Lyn – a Src family kinase to the clustered EGFR at the plasma membrane (Figure 
3.11). Treatment with PP2 inhibits the tyrosine phosphorylation of paxillin co-localized with 
these clusters, and this treatment causes a small increase in the recruitment of paxillin-GFP and 
phospho-Ser-paxillin as quantified by Pearson’s correlation coefficients (Figure 3.6). This 
suggests enhanced association of paxillin with clustered EGFR in absence of Src kinase activity. 
However, the activity of Src kinase is not critical for the activation of Erk, as shown in 
experiments with patterned EGF as well as with soluble EGF (data not shown). In contrast, other 
studies demonstrated reduced Erk activation in presence of PP2 in prostate cancer cells (10). 
This difference in observation is possibly due to difference in the cell types and different 
contributions of other signaling pathways, such as formation of focal adhesions contributing to 
activation of Erk kinase.   
To investigate further the role of paxillin in the formation these EGFR signaling 
complexes, we knocked down paxillin using siRNA. Our results show that paxillin knock down 
does not affect early steps in EGFR activation or the recruitment of Ras and F-actin to the EGFR 
signaling complexes (Figure 3.15, 3.17). However, it significantly (p = 0.0049) reduces the 
recruitment of Erk to these EGFR signaling complexes in 3T3 cells (Figure 3.16). In contrast, 
paxillin knock down does not inhibit phosphorylation of Erk upon stimulation with soluble EGF 
in NIH-3T3 cells (Figure 3.16). This result contrasts with previous observations, in which 
paxillin knock down in PC3 cells caused abrogation of activation of Erk upon treatment with 
soluble EGF (10). Again, this might also be due to differences between the cell types. Our results 
showing reduced recruitment of phosphorylated Erk to clustered, activated EGFR in cells due to 
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paxillin knock down indicate that paxillin contributes to stabilization of the EGFR signaling 
complexes.  
Our previous experiments on the FcεRI receptor signaling system with micro-patterned 
ligands showed that F-actin is recruited to the clustered FcεRI complexes (11, 12). We also 
observed that Lyn, a Src family kinase, responsible for phosphorylation of FcεRI receptor, is 
recruited to clustered FcεRI. Large scale accumulation of Lyn over patterned ligands is inhibited 
by cytochalasin D. In contrast, in presence of cytochalasin D, tyrosine phosphorylation of FcεRI 
receptor upon stimulation with soluble antigen is enhanced (11). Based on these previous 
experiments we hypothesized that actin cytoskeleton stabilizes EGFR signaling complexes on 
the plasma membrane. Our results show recruitment of F-actin to the EGF-clustered EGFR 
(Figure 3.8), whereas the actin binding proteins ezrin and moesin do not visibly co-redistribute 
with EGF patterns. Consistent with our observations with FcεRI receptor complexes, we find 
that, in presence of cytochalasin D, there is no detectable recruitment of more downstream 
partners such as paxillin, H-Ras and Erk to the EGFR signaling complex at the plasma 
membrane (Figure 3.10 and data not shown). In contrast pretreatment with cytochalasin D did 
not inhibit the recruitment or tyrosine phosphorylation of EGFR or recruitment of dynamin 2 in a 
ligand-dependent manner. We found that stimulation with soluble EGF in presence of 
cytochalasin D caused ~50% decrease in Erk activation in NIH-3T3 (EGFR) cells (Figure 3.10 C 
and D), whereas a previous study showed no effect of cytochalasin D on EGFR-dependent 
activation of Erk in Rat 1a fibroblasts (38). These results indicate some cell type differences in 
the role of F-actin in stabilizing macromolecular signaling complexes formed with clustered 
EGFR at the plasma membrane.  
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Paxillin, F-actin and integrins are also known to participate in the formation of focal 
adhesion complexes, the macromolecular structures that are formed on the sites of cells 
interaction with extracellular matrix (33), and Erk is known to be activated via integrin-
fibronectin mediated signaling through focal adhesions (44). We find that α-5 integrin-GFP, 
which is the most abundant integrin  chain in NIH-3T3 cells (34), is excluded from the EGFR 
signaling complexes at the plasma membrane. This indicates that the EGFR signaling complexes 
that are formed on the sites of micro-patterned EGF are independent of formation of focal 
adhesions at these sites.  
Once EGFR is activated after binding EGF, it is normally endocytosed  (5). In our 
experiments with micro-patterned EGF surfaces, we find that clathrin is visibly concentrated 
over EGF patterns in ~35% of the cells (data not shown). In contrast, we observe the recruitment 
of dynamin 2, a GTPase implicated for its role in both clathrin-dependent (54) and clathrin-
independent endocytosis (55), to the clustered EGFR in >90% of cells. The actin cytoskeleton 
has also been implicated in endocytosis of EGFR (56). These two results suggest that proteins 
recruited to clustered EGFR may also be a part of the EGFR endocytic pathway, even though the 
endocytosis of EGFR is prevented, as EGF is covalently immobilized on the silicon substrate.  
Phosphoinositides are known to play important roles in cell signaling in all cell types, as 
well as in receptor endocytosis (41).  Our results indicate that recruitment of F-actin (Figure 
3.12) and p-Erk (Figure 3.13) are inhibited by pretreatment with PAO or quercetin, which inhibit 
phosphoinositide synthesis in cells. Stimulation of Erk activation by soluble EGF was not 
inhibited by these compounds, as determined by western blotting experiments (data not shown). 
PI(4,5)P2 has also been implicated in the reorganization of actin cytoskeleton (57), so our 
observed lack of recruitment of p-Erk to the clustered EGFR in presence of PAO or quercetin 
163 
 
might be an indirect consequence of inhibition of recruitment of F-actin. Our results also 
demonstrate that dynamin 2, which has a PH domain (43), is not recruited to the EGFR signaling 
complex in presence of PAO or quercetin (Figure 3.14), even though its recruitment is not 
affected by cytochalasin-D pretreatment (data not shown). This suggests that dynamin 2 
recruitment to the EGFR signaling complex are driven by interactions with PI(4,5)P2, 
independent of actin cytoskeleton. This is also consistent with some of our previous observations 
highlighting the role of dynamin 2 in the organization of actin cytoskeleton at the sites of 
activated FcεRI receptor in RBL-2H3 cells (Chapter 2). However, to test the role of dynamin 2 in 
the organization of F-actin at EGFR signaling complexes, dynamin 2 knock down experiments 
will need to be evaluated.  
Our attempts to directly probe the concentration of PI(4,5)P2 at the sites of EGF patterns 
by utilizing a GFP tagged PH domain-PLC-δ (58) did not reveal concentration of this marker co-
localized with EGF patterns (data not shown). However, we note that the PH domain PLC-δ 
binds specifically but weakly to PI(4,5)P2, and other, high avidity proteins will compete 
effectively for available PI(4,5)P2. In addition, we observe recruitment of PLCγ1-GFP, which is 
known to interact with phosphorylated EGFR via its SH2 domains. PLCγ1-GFP mediates 
hydrolysis of PI(4,5)P2 to IP3 and DAG, which might further reduce the pool of accessible 
PI(4,5)P2 for PH-domain-PLCδ at the EGFR signaling complexes. In combination, these results 
suggest that stimulated synthesis of PI(4,5)P2 occurs at the micron sized EGFR signaling 
complexes at the plasma membrane to play a role in recruitment of other proteins such as F-
actin-binding proteins and dynamin 2, directly or through regulation of adaptor proteins. 
However, directly assessing the local concentration of PI(4,5)P2 at these micron sized EGFR 
signaling complexes on the plasma membrane may be difficult.  
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In conclusion, we have shown that micropatterned EGF surfaces are a useful tool to study 
the spatial aspects of the EGFR signaling that complements the biochemical tools such as 
immunoprecipitations and co-immunoprecipitations to detect the interactions of signaling 
partners with EGFR. Figure 3.18 schematically depicts the formation of the macro-molecular 
signaling complexes with clustered, EGF-bound EGFR on the plasma membrane of cells. Table 
3.1 summarizes results from the different experiments described in this chapter to investigate 
EGFR signaling partners with clustered EGFR on the plasma membrane. Our experiments with 
immobilized EGF patterns show formation of macromolecular EGFR signaling complexes, 
including EGFR signaling partners PLCγ1, H- and N-Ras, MEK, and Erk, in addition to paxillin, 
F-actin, and dynamin-2. Our results provide strong evidence that phosphoinositide synthesis and 
the actin cytoskeleton play important roles in the stabilization of these EGFR signaling 
complexes. However, the structural basis of formation of these complexes is still incompletely 
understood. Formation of macro-molecular clusters of EGFR that are restricted from undergoing 
stimulated endocytosis, an important pathway for the down regulation of receptor activated 
signaling, may result in some non-physiological consequences. We note that capacity to detect 
signaling partners is limited by the sensitivity of fluorescent labeling of proteins and their 
concentration at the sites of clustered EGFR. Recruitment of some functionally relevant proteins 
may be difficult to detect.  
Further experiments will be necessary to determine the sequence in which the signaling 
partners such as Ras, PI3-kinase, and PLCγ are recruited to the EGFR complex on the plasma 
membrane. These micro-patterned surfaces may also be utilized to understand the cross-talk 
between EGFR and other receptor signaling pathways such as integrin-mediated signaling. These  
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Proteins Control PP2 Iressa PAO/Querceti
n 
Cyto D 
(2μM) 
EGFR Yes Yes Yes Yes Yes 
P-EGFR Yes Yes None Yes Yes 
P-Tyr Yes Yes Very weak Yes Yes 
Paxillin-GFP Yes Yes None None None 
p-Tyr-Paxillin Yes None - - - 
p-Ser-Paxillin Yes Yes - - - 
F-actin Yes Yes None None None 
Ezrin None - - - - 
Moesin None - - - - 
H-Ras-GFP Yes Yes - - None 
MEK Yes - - - None 
P-Erk Yes - - None None 
PLCγ1-GFP Yes - - - - 
α5-Integrin-GFP Excluded  - - - 
Dynamin 2-GFP Yes - - None Yes 
 
Table 3.1 Observations from different experiments with NIH-3T3 (EGFR) cells: A ‘Yes’ 
indicates that proteins could be optically resolved as colocalized with micro-patterned EGF 
bound to EGFR, ‘None’ indicates no clustering was visually observed, and ‘-‘ indicates that the 
experiment was not performed.   
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Figure 3.18: Immobilized, micro-patterned EGF on silicon substrate forms actin 
cytoskeleton dependent EGFR signaling complexes: The schematic shows that the 
EGFR signaling complexes formed on the plasma membrane consists of phosphorylated 
EGFR, paxillin, MEK and pErk. Dynamin 2. PLCγ and F-actin are also recruited to these 
signaling complexes at the plasma membrane. Inhibitors of F-actin polymerization and 
phosphoinositide synthesis, do not affect the EGF dependent phosphorylation of Erk, but 
abolish any detectable recruitment of pErk to micro-patterned EGF surfaces.  
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micro-patterned ligand surfaces open new avenues to explore spatiotemporal regulation of 
receptor mediated signaling.    
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Chapter 4 
Summary and Future Directions: 
 
4.1 FcεRI internalization: 
Endocytosis of ligand-bound, activated receptors is usually considered as a means to down 
regulate signaling cascades initiated by activation of the receptor. Recent studies have indicated 
that some receptors continue their signaling from inside the endosomes, and signals emanated 
from these endosomal receptors may be different from those activated by  receptors at the plasma 
membrane (1). Elucidating mechanisms of receptor internalization will shed more light on 
understanding receptor mediated signaling events. Receptor endocytosis may occur via a variety 
of mechanisms, some of which are reviewed here (2). In the pathways utilized for receptor 
endocytosis, the roles of clathrin and dynamin 2 have been widely studied. Clathrin is a protein 
known to play a critical role in shaping the budding vesicles and sorting them to their 
destinations. Dynamin 2, a GTPase, is primarily responsible for scission of newly formed 
vesicles from the plasma membrane (3).  
Previous studies have shown that IgE bound FcεRI is endocytosed rapidly at 37°C (t1/2 ~ 5 
minutes) in response to crosslinking with antigen (4, 5). Prior studies that FcεRI internalization is 
dependent on Lyn kinase in bone marrow-derived mast cells (BMMCs) (6),although others have 
reached a different conclusion in rat basophilic leukemia (RBL) cells (7). The roles of clathrin, 
dynamin 2, and actin cytoskeleton were not clearly understood. While most of the studies 
focused on FcεRI receptor internalization have utilized an acid-stripping method or flow 
cytometry to quantify internalization, we have implemented a several different approaches 
including fluorescence spectroscopy, confocal microscopy, and flow cytometry to assess FcεRI 
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internalization. Employing a combination of these methods, we demonstrate that, in certain 
circumstances, aggregated FcεRI receptors are located in membrane invaginations, but they are 
not pinched off from the plasma membrane. In these situations, the surface labeling antibodies 
that are used for detection in flow cytometry do not label the receptors in membrane 
invaginations that are not cleaved from the plasma membrane. This result indicates that flow 
cytometry alone may sometimes lead to misinterpretation of the fate of these receptors in 
membrane invaginations as internalized receptors, and thus may not be an adequate method for 
quantifying receptor internalization. These limitations may be overcome by a more 
comprehensive assessment of receptor internalization utilizing spectroscopic and microscopic 
approaches, in addition to flow cytometry measurements. Thus, a multifaceted approach using a 
combination of different methods will be helpful to better understand the endocytic state of the 
receptors.  
Previously, our lab employed micro-patterned ligand surfaces in combination with confocal 
fluorescent microscopy to study the formation of IgE-FcεRI signaling complexes at the plasma 
membrane of RBL-2H3 cells (8). FcεRI is activated upon binding to its co-localized ligand in 
micro-patterned liganded bilayers, which leads to recruitment of downstream signaling partners 
including Lyn, a Src family kinase that is responsible for receptor phosphorylation. Experiments 
with these surfaces revealed that actin cytoskeleton-regulating proteins such as paxillin, vinculin, 
and talin are also recruited to these FcεRI signaling complexes in addition to accumulation of F-
actin (9). Here, we demonstrate that activated dynamin 2 is recruited to FcεRI signaling 
complexes, and, furthermore, it regulates the organization of F-actin at these sites. In light of this 
result, two mechanisms are possible: 1) A direct connection between FcεRI signaling 
components and actin cytoskeleton regulating proteins and/or 2) Dynamin 2 operating as an 
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adapter protein that coordinates protein-protein interactions for signaling leading to 
degranulation and/or regulation and assembly of FcεRI endocytic machinery.  
In our experiments to assess internalization, we have determined that FcεRI internalization is 
sensitive to cholesterol and the phosphoinositide content of the plasma membrane. In the 
presence of inhibitors of F-actin polymerization, a significant (~60%) fraction of aggregated 
FcεRI is in membrane invaginations that are not cleaved from the plasma membrane. This 
indicates that the actin cytoskeleton plays a role in cleaving budding endosomes from the plasma 
membrane. A plausible mechanism for cytoskeletal regulation of FcεRI internalization is 
depicted in Figure 4.1. After FcεRI activation, dynamin 2 is recruited to the FcεRI signaling 
complex, where it may regulate the selective accumulation of several actin binding proteins. This 
then leads to the formation of a cytoskeletal network, which may help in generating the 
contractile forces and membrane curvature in combination with BAR domain containing 
proteins, which induce and stabilize membrane curvature. In this model, the endocytic structure 
depicted in Figure 4.1 leads to internalization of vesicles containing clustered IgE-FcεRI 
complexes. 
Further studies with selective knock down experiments will be required to determine the role of 
the other proteins such as BAR domain containing proteins and cytoskeletal adaptor proteins, 
such as actin related protein (Arp2/3) and Wiskott-Aldrich syndrome protein (WASP). Further 
biochemical characterization is needed to differentiate between the roles of dynamin-2 and actin 
cytoskeleton adapter proteins, both in FcεRI signaling and as regulators of FcεRI internalization. 
Co-immunoprecipitation studies may provide specific information about the proteins interacting 
with dynamin 2 and actin cytoskeletal adaptor proteins occurring after FcεRI activation. Further  
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Figure 4.1: A model for regulation of FcεRI endocytosis by dynamin 2: Dynamin 2 
is recruited to FcεRI following aggregation of IgE bound receptors. Dynamin 2 then 
plays a role in recruitment of actin cytsokeletal regulating proteins and F-actin assembly 
at the IgE-FcεRI signaling complexes. Contractile forces induced by F-actin and 
dynamin, in colaboration with BAR domain proteins are responsible for the formation 
of endocytic vessicles containing the activated receptors. These vesicles are then 
cleaved via the fission mediated by GTPase activity of dynamin 2 (Reproduced from 
reference (5)). 
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experiments will be required to understand the importance of FcεRI aggregation in ordered 
membrane domains and the role of phospholipids in its internalization. Utilization of micro-
patterned surfaces in conjunction with cholesterol and phosphoinositide perturbations will be 
helpful in determining the role of plasma membrane composition in the recruitment of signaling 
partners and/or components of endocytic machinery to FcεRI signaling complexes.    
Furthermore, it should be noted that micro-patterned ligand surfaces provide a useful way of 
stimulating cells, wherein the cell cannot internalize activated, ligand-bound FcεRI. Previous 
studies with Fc receptors have shown that particles < 1μm are endocytosed, whereas particles > 
1μm are phagocytosed (10). Further experiments must be performed to characterize whether 
these liganded surfaces resemble a case of frustrated endocytosis or phagocytosis. It is 
conceivable that varying feature sizes on micro-patterned surfaces may show different cellular 
responses. For example, feature sizes < 500 nm could initiate a cellular response that will closely 
resemble endocytosis, which will be different from the responses seen in feature sizes ≥ 1 μm.  
With further advances in the nano/microfabriaction schemes utilized to synthesize these 
patterned substrates, lower feature sizes will be more available for experiments.  
 
4.2 Spatial regulation of EGFR signaling with micro-patterned ligand surfaces 
EGFR regulation of cell growth has been widely implicated in various cancers (11, 12). Here, we 
determined that micro-patterned surfaces of covalently immobilized EGF can activate the EGFR 
on the surface of cells. We observed the recruitment and phosphorylation of the adaptor protein 
paxillin to EGFR signaling complexes formed on the plasma membrane, which was previously 
implicated to play a role in EGFR signaling (13, 14). We demonstrated that, in addition to 
paxillin, F-actin is also recruited to the EGFR signaling complex, but integrin α-5 GFP is 
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excluded from these complexes.  Our experiments demonstrated the recruitment of previously 
known signaling partners to the EGF-EGFR clusters: H-Ras, MEK, Erk and PLCγ. We also 
demonstrated that F-actin polymerization plays an important role in the stable recruitment of H-
Ras and Erk to the EGFR signaling complex. 
We also observed recruitment of dynamin 2 to the micro-patterned, immobilized EGF patches. 
Dynamin 2 is recruited to the EGF-containing surfaces, even in the presence of inhibitors of F-
actin polymerization. This indicates that unlike H-Ras, pErk, and paxillin recruitment, dynamin-
2 recruitment does not depend on the actin cytoskeleton. Since EGFR is also internalized upon 
activation by a dynamin 2 and an actin cytoskeleton-dependent mechanism (15), it is plausible 
that dynamin 2 might be playing a role in the recruitment of F-actin to the micro-patterned 
surfaces, which form the EGFR endocytic machinery. Recruitment of dynamin 2, F-actin, and 
Erk is diminished in presence of PAO or quercetin, inhibitors for phosphatidylinositol 4,5 
bisphosphate (PI(4,5)P2) synthesis, which indicates a role for phosphoinositides in the formation 
of EGFR signaling complexes. This raises two scenarios: 1) Phosphoinositides directly play a 
role in the recruitment of proteins such as dynamin 2 and actin adaptor proteins (N-WASP, 
radixin) by binding to their PH domains and/or 2) Phosphoinositides regulate the recruitment of 
the actin cytoskeleton to the EGFR signaling complexes at the plasma membrane, which in turn 
plays a role in the recruitment of signaling partners such as paxillin, H-Ras, and pErk.  
It should be kept in mind that surface attached, immobilized ligands is possibly un-physiological 
method of stimulating the cells. The macromolecular receptor signaling complexes formed are 
not endocytosed and may continue signaling for longer time, in comparison to the case of 
stimulation with soluble ligands. In light of some recent evidence, which demonstrates that 
EGFR in endosomes is capable of signaling (1), more effort should be made to understand the 
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nature of receptor complexes at the plasma membrane. Furthermore, the structural basis of the 
formation of these signaling complexes on the plasma membrane of the cells is not well 
understood. Future experiments utilizing pharmacological inhibitors and specific protein knock 
downs will be required to determine the sequelae of interactions of proteins involved in the 
signaling complex and their effect on the formation of complex.  
EGFR is known to be involved in cross-talk with other receptor mediated signaling pathways, 
which include G-protein coupled receptors (GPCR) (16) and integrins (17). Utilization of micro-
patterned surfaces can help to elucidate the spatial interactions of the components of these 
signaling pathways. For example, we have demonstrated that integrin α-5 is excluded from the 
EGFR signaling complexes formed by stimulating with micro-patterned EGF. EGFR can be also 
activated by other EGF-like ligands, such as amphiregulin, transforming growth factor α (TGFα) 
and heparin-binding EGF-like growth factor (HB-EGF) (11), which adds another layer of 
signaling diversification in the regulation of EGFR activity.  A recent investigation demonstrated 
that EGFR conformation change after binding with TGFα is different from the conformational 
changes it undergoes after binding with EGF (18). This may provide the structural basis for 
differential recruitment of signaling partners to increase the diversity in EGFR signaling 
responses after stimulation with different ligands. Substrates micro-patterned with these EGF-
like ligands may be used to determine if EGFR activated by other ligands has a different 
recruitment of signaling partners as compared to stimulation with EGF.  
 
4.3 Micro-patterned ligand surfaces to study receptor mediated signaling:  
Cell biologists deal with a lot of complexities in their experimental systems, which makes it hard 
to interpret experimental results, and further necessitates combining multiple approaches to 
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establish a mechanism beyond reasonable doubt. In the past few years, tools developed by 
advances in physical sciences, such as fluorescent spectroscopy, genetically modified fluorescent 
tags, and confocal microscopy, have helped in expanding the tool set available to experimental 
cell biologists. Moreover, development of micro/nano-fabricated ligand patterns have provided 
an option of spatially controlling the stimuli provided to the cells (19). We previously utilized 
these surfaces to spatially control the stimulation of FcεRI receptor on mast cells to study the 
spatio-temporal aspects of FcεRI signaling leading to degranulation.  
Here, we demonstrate that utilizing these micro-patterned surfaces, in combination with 
fluorescence spectroscopy and flow cytometery, provides new insights about the role of dynamin 
in assembly of FcεRI endocytic machinery. We also extended the use of micro-patterned ligand 
surfaces to study spatio-temporal aspects of EGFR signaling. With further advances in 
lithographic techniques to reduce the feature sizes and surface functionalization schemes for 
depositing functionally active biological substrates, we will be able to stimulate cells in a 
spatially controlled manner close to physiological conditions. Advances in sub-optical resolution 
fluorescence microscopy and other imaging techniques will allow us to obtain a detailed 
visualization of the spatial assembly signaling complexes. This understanding will be helpful to 
answer the basic questions of how cells respond to external stimuli.  
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